This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-107 | ACVR1 | 1.49 | 0.00013 | -0.76 | 0.04389 | miRanda | -0.13 | 0.02288 | NA | |
2 | hsa-miR-142-3p | ACVR1 | 4.35 | 0 | -0.76 | 0.04389 | miRanda | -0.17 | 0 | NA | |
3 | hsa-miR-148b-3p | ACVR1 | 1.76 | 0 | -0.76 | 0.04389 | MirTarget | -0.32 | 0 | NA | |
4 | hsa-miR-16-2-3p | ACVR1 | 3.8 | 0 | -0.76 | 0.04389 | mirMAP | -0.12 | 0.00315 | NA | |
5 | hsa-miR-186-5p | ACVR1 | 0.45 | 0.18545 | -0.76 | 0.04389 | miRNAWalker2 validate | -0.3 | 0 | NA | |
6 | hsa-miR-197-3p | ACVR1 | 1.24 | 0.00733 | -0.76 | 0.04389 | miRNAWalker2 validate | -0.11 | 0.02374 | NA | |
7 | hsa-miR-19b-3p | ACVR1 | 1.68 | 0.00086 | -0.76 | 0.04389 | miRNAWalker2 validate | -0.16 | 0.00012 | NA | |
8 | hsa-miR-30b-5p | ACVR1 | 0.02 | 0.95322 | -0.76 | 0.04389 | MirTarget | -0.17 | 0.00144 | NA | |
9 | hsa-miR-30c-5p | ACVR1 | 0.39 | 0.34861 | -0.76 | 0.04389 | MirTarget; miRNATAP | -0.17 | 0.001 | NA | |
10 | hsa-miR-30d-5p | ACVR1 | 0.3 | 0.38019 | -0.76 | 0.04389 | MirTarget; miRNATAP | -0.14 | 0.03381 | NA | |
11 | hsa-miR-30e-5p | ACVR1 | 0.78 | 0.03467 | -0.76 | 0.04389 | MirTarget | -0.29 | 0 | NA | |
12 | hsa-miR-320a | ACVR1 | -0.91 | 0.05656 | -0.76 | 0.04389 | miRanda | -0.13 | 0.00356 | NA | |
13 | hsa-miR-338-3p | ACVR1 | 0.45 | 0.55849 | -0.76 | 0.04389 | MirTarget; PITA; miRanda; miRNATAP | -0.11 | 5.0E-5 | NA | |
14 | hsa-miR-362-3p | ACVR1 | 0.68 | 0.22615 | -0.76 | 0.04389 | miRanda | -0.14 | 0.00018 | NA | |
15 | hsa-miR-454-3p | ACVR1 | 1.4 | 0.00366 | -0.76 | 0.04389 | MirTarget; miRNATAP | -0.12 | 0.00599 | NA | |
16 | hsa-miR-590-3p | ACVR1 | 2.35 | 0 | -0.76 | 0.04389 | miRanda | -0.21 | 0 | NA | |
17 | hsa-let-7d-5p | ACVR1C | 0.83 | 0.0127 | 1.69 | 0.1187 | MirTarget; miRNATAP | -0.37 | 0.04936 | NA | |
18 | hsa-let-7e-5p | ACVR1C | -0.11 | 0.81474 | 1.69 | 0.1187 | MirTarget; miRNATAP | -0.53 | 5.0E-5 | NA | |
19 | hsa-let-7g-5p | ACVR1C | 0.86 | 0.00648 | 1.69 | 0.1187 | MirTarget; miRNATAP | -0.48 | 0.01705 | NA | |
20 | hsa-miR-129-5p | ACVR1C | -2.67 | 0.00696 | 1.69 | 0.1187 | miRanda | -0.18 | 0.00498 | NA | |
21 | hsa-miR-130a-5p | ACVR1C | 1.58 | 0.02435 | 1.69 | 0.1187 | miRNATAP | -0.28 | 0.00144 | NA | |
22 | hsa-miR-181b-5p | ACVR1C | 1.11 | 0.02734 | 1.69 | 0.1187 | miRNATAP | -0.31 | 0.01166 | NA | |
23 | hsa-miR-181c-5p | ACVR1C | -0.3 | 0.53753 | 1.69 | 0.1187 | miRNATAP | -0.28 | 0.02714 | NA | |
24 | hsa-miR-26b-5p | ACVR1C | 0.31 | 0.46163 | 1.69 | 0.1187 | MirTarget; miRNATAP | -0.31 | 0.03643 | NA | |
25 | hsa-miR-335-3p | ACVR1C | 1.2 | 0.09389 | 1.69 | 0.1187 | MirTarget | -0.17 | 0.04358 | NA | |
26 | hsa-miR-7-1-3p | ACVR1C | 1.43 | 0.00471 | 1.69 | 0.1187 | mirMAP | -0.26 | 0.03453 | NA | |
27 | hsa-let-7i-5p | ACVR2A | 0.05 | 0.86971 | -0.45 | 0.27609 | miRNATAP | -0.21 | 0.01256 | NA | |
28 | hsa-miR-142-3p | ACVR2A | 4.35 | 0 | -0.45 | 0.27609 | MirTarget; PITA; miRanda; miRNATAP | -0.11 | 0.00043 | NA | |
29 | hsa-miR-181a-5p | ACVR2A | 1.26 | 0.00749 | -0.45 | 0.27609 | MirTarget; miRNATAP | -0.1 | 0.03491 | NA | |
30 | hsa-miR-193b-5p | ACVR2A | 0.45 | 0.56588 | -0.45 | 0.27609 | MirTarget | -0.13 | 1.0E-5 | NA | |
31 | hsa-miR-21-5p | ACVR2A | 2.65 | 0 | -0.45 | 0.27609 | miRNATAP | -0.24 | 0.0004 | NA | |
32 | hsa-miR-27a-3p | ACVR2A | 1.76 | 0.00022 | -0.45 | 0.27609 | miRNATAP | -0.14 | 0.00463 | NA | |
33 | hsa-miR-29a-3p | ACVR2A | -0.64 | 0.25192 | -0.45 | 0.27609 | miRNATAP | -0.18 | 2.0E-5 | NA | |
34 | hsa-miR-29a-5p | ACVR2A | 0.07 | 0.88413 | -0.45 | 0.27609 | mirMAP; miRNATAP | -0.21 | 0 | NA | |
35 | hsa-miR-29b-3p | ACVR2A | 0.67 | 0.23406 | -0.45 | 0.27609 | miRNATAP | -0.18 | 1.0E-5 | NA | |
36 | hsa-miR-331-5p | ACVR2A | 1.03 | 0.02625 | -0.45 | 0.27609 | PITA | -0.11 | 0.02976 | NA | |
37 | hsa-let-7b-3p | ACVR2B | 0.59 | 0.20051 | -0.47 | 0.3473 | MirTarget | -0.23 | 0.00019 | NA | |
38 | hsa-let-7f-1-3p | ACVR2B | 1.62 | 0.00069 | -0.47 | 0.3473 | MirTarget | -0.2 | 0.00088 | NA | |
39 | hsa-miR-142-5p | ACVR2B | 3.96 | 0 | -0.47 | 0.3473 | PITA | -0.17 | 1.0E-5 | NA | |
40 | hsa-miR-342-5p | ACVR2B | 1.39 | 0.01536 | -0.47 | 0.3473 | miRNATAP | -0.18 | 0.00022 | NA | |
41 | hsa-miR-455-3p | ACVR2B | 2.19 | 0.00137 | -0.47 | 0.3473 | miRNATAP | -0.14 | 0.00069 | NA | |
42 | hsa-miR-455-5p | ACVR2B | -0.32 | 0.6163 | -0.47 | 0.3473 | PITA | -0.16 | 0.00028 | NA | |
43 | hsa-let-7a-5p | BMP2 | 0.15 | 0.64531 | 0.6 | 0.59614 | TargetScan | -0.43 | 0.03668 | NA | |
44 | hsa-miR-106a-5p | BMP2 | 3.99 | 0 | 0.6 | 0.59614 | miRNATAP | -0.28 | 0.0002 | NA | |
45 | hsa-miR-362-3p | BMP2 | 0.68 | 0.22615 | 0.6 | 0.59614 | miRanda | -0.39 | 0.0006 | NA | |
46 | hsa-miR-378c | BMP2 | 0.45 | 0.49938 | 0.6 | 0.59614 | miRNATAP | -0.28 | 0.0034 | NA | |
47 | hsa-miR-429 | BMP2 | 6.4 | 0 | 0.6 | 0.59614 | miRNATAP | -0.32 | 0.00011 | NA | |
48 | hsa-miR-142-3p | BMP4 | 4.35 | 0 | -1.95 | 0.0822 | PITA; miRanda | -0.38 | 2.0E-5 | NA | |
49 | hsa-miR-590-3p | BMP4 | 2.35 | 0 | -1.95 | 0.0822 | miRanda | -0.37 | 0.00319 | NA | |
50 | hsa-miR-125a-3p | BMP7 | -0.07 | 0.92074 | 2.47 | 0.14183 | miRanda | -0.6 | 0 | NA | |
51 | hsa-miR-30a-5p | BMP7 | -0.77 | 0.32049 | 2.47 | 0.14183 | mirMAP; miRNATAP | -0.84 | 0 | NA | |
52 | hsa-miR-338-3p | BMP7 | 0.45 | 0.55849 | 2.47 | 0.14183 | miRanda | -0.68 | 0 | NA | |
53 | hsa-miR-616-5p | BMP7 | 2.48 | 0.00318 | 2.47 | 0.14183 | mirMAP | -0.31 | 0.03095 | NA | |
54 | hsa-miR-142-3p | BMP8A | 4.35 | 0 | -0.91 | 0.14941 | miRNAWalker2 validate | -0.15 | 0.00247 | NA | |
55 | hsa-miR-30e-3p | BMP8A | -0.04 | 0.93258 | -0.91 | 0.14941 | MirTarget | -0.27 | 0.00121 | NA | |
56 | hsa-miR-326 | BMP8A | 1.77 | 0.03673 | -0.91 | 0.14941 | miRanda | -0.12 | 0.00459 | NA | |
57 | hsa-miR-330-5p | BMP8A | 2.25 | 0.00028 | -0.91 | 0.14941 | miRanda | -0.14 | 0.014 | NA | |
58 | hsa-miR-423-5p | BMP8A | 0.23 | 0.56535 | -0.91 | 0.14941 | MirTarget | -0.18 | 0.04602 | NA | |
59 | hsa-miR-125a-3p | BMP8B | -0.07 | 0.92074 | 2.55 | 0.00041 | miRanda | -0.13 | 0.0158 | NA | |
60 | hsa-miR-125a-5p | BMP8B | -1.32 | 0.00714 | 2.55 | 0.00041 | miRanda | -0.22 | 0.00973 | NA | |
61 | hsa-miR-150-5p | BMP8B | 1.77 | 0.05938 | 2.55 | 0.00041 | mirMAP | -0.1 | 0.02078 | NA | |
62 | hsa-miR-181a-5p | BMP8B | 1.26 | 0.00749 | 2.55 | 0.00041 | mirMAP | -0.17 | 0.04884 | NA | |
63 | hsa-miR-181b-5p | BMP8B | 1.11 | 0.02734 | 2.55 | 0.00041 | mirMAP | -0.19 | 0.01825 | NA | |
64 | hsa-miR-181c-5p | BMP8B | -0.3 | 0.53753 | 2.55 | 0.00041 | mirMAP | -0.18 | 0.0358 | NA | |
65 | hsa-miR-26b-5p | BMP8B | 0.31 | 0.46163 | 2.55 | 0.00041 | miRNAWalker2 validate | -0.34 | 0.00051 | NA | |
66 | hsa-miR-455-5p | BMP8B | -0.32 | 0.6163 | 2.55 | 0.00041 | miRanda | -0.19 | 0.00365 | NA | |
67 | hsa-miR-942-5p | BMPR1A | 3.36 | 0 | -1.12 | 0.02074 | MirTarget | -0.12 | 0.02233 | NA | |
68 | hsa-miR-142-5p | BMPR1B | 3.96 | 0 | -1.52 | 0.34339 | mirMAP | -0.73 | 0 | NA | |
69 | hsa-miR-146b-5p | BMPR1B | 1.88 | 0.00074 | -1.52 | 0.34339 | miRanda | -0.67 | 4.0E-5 | NA | |
70 | hsa-miR-150-5p | BMPR1B | 1.77 | 0.05938 | -1.52 | 0.34339 | MirTarget | -0.47 | 0 | NA | |
71 | hsa-miR-205-5p | BMPR1B | 8.08 | 0 | -1.52 | 0.34339 | miRNATAP | -0.31 | 0 | NA | |
72 | hsa-miR-23a-3p | BMPR1B | 0.93 | 0.01273 | -1.52 | 0.34339 | mirMAP | -0.6 | 0.01516 | NA | |
73 | hsa-miR-23b-3p | BMPR1B | -0.58 | 0.19048 | -1.52 | 0.34339 | mirMAP | -0.74 | 0.00035 | NA | |
74 | hsa-miR-24-3p | BMPR1B | 1.56 | 0.00052 | -1.52 | 0.34339 | miRNATAP | -0.55 | 0.00635 | NA | |
75 | hsa-miR-374a-5p | BMPR1B | 0.28 | 0.45888 | -1.52 | 0.34339 | MirTarget | -0.88 | 0.00036 | NA | |
76 | hsa-miR-590-3p | BMPR1B | 2.35 | 0 | -1.52 | 0.34339 | miRanda; mirMAP | -0.55 | 0.00205 | NA | |
77 | hsa-miR-629-3p | BMPR1B | 3.48 | 0 | -1.52 | 0.34339 | MirTarget | -0.42 | 0.00285 | NA | |
78 | hsa-let-7a-3p | BMPR2 | 0.83 | 0.04681 | -1.13 | 0.00109 | MirTarget; miRNATAP | -0.11 | 0.01644 | NA | |
79 | hsa-let-7f-1-3p | BMPR2 | 1.62 | 0.00069 | -1.13 | 0.00109 | MirTarget | -0.12 | 0.00286 | NA | |
80 | hsa-miR-106b-5p | BMPR2 | 2.81 | 0 | -1.13 | 0.00109 | MirTarget; miRNATAP | -0.12 | 0.00443 | NA | |
81 | hsa-miR-146b-3p | BMPR2 | 1.35 | 0.00936 | -1.13 | 0.00109 | MirTarget; PITA | -0.13 | 0.00059 | NA | |
82 | hsa-miR-148b-3p | BMPR2 | 1.76 | 0 | -1.13 | 0.00109 | mirMAP | -0.2 | 0.00099 | NA | |
83 | hsa-miR-16-2-3p | BMPR2 | 3.8 | 0 | -1.13 | 0.00109 | mirMAP | -0.15 | 6.0E-5 | NA | |
84 | hsa-miR-17-5p | BMPR2 | 2.33 | 2.0E-5 | -1.13 | 0.00109 | miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP | -0.12 | 0.00049 | NA | |
85 | hsa-miR-19b-3p | BMPR2 | 1.68 | 0.00086 | -1.13 | 0.00109 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.15 | 0.0001 | NA | |
86 | hsa-miR-20a-5p | BMPR2 | 2.14 | 0.00018 | -1.13 | 0.00109 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.11 | 0.00126 | NA | |
87 | hsa-miR-21-5p | BMPR2 | 2.65 | 0 | -1.13 | 0.00109 | miRNAWalker2 validate; miRTarBase; MirTarget | -0.12 | 0.03687 | NA | |
88 | hsa-miR-25-3p | BMPR2 | 1.13 | 0.00311 | -1.13 | 0.00109 | miRNATAP | -0.16 | 0.00181 | NA | |
89 | hsa-miR-30b-5p | BMPR2 | 0.02 | 0.95322 | -1.13 | 0.00109 | mirMAP | -0.17 | 0.00068 | NA | |
90 | hsa-miR-30e-5p | BMPR2 | 0.78 | 0.03467 | -1.13 | 0.00109 | mirMAP | -0.15 | 0.00461 | NA | |
91 | hsa-miR-32-5p | BMPR2 | 2.93 | 0 | -1.13 | 0.00109 | miRNATAP | -0.15 | 0.00016 | NA | |
92 | hsa-miR-590-3p | BMPR2 | 2.35 | 0 | -1.13 | 0.00109 | MirTarget; miRanda; mirMAP; miRNATAP | -0.18 | 0 | NA | |
93 | hsa-miR-590-5p | BMPR2 | 1.51 | 0.00239 | -1.13 | 0.00109 | MirTarget; PITA; miRNATAP | -0.15 | 0.00015 | NA | |
94 | hsa-miR-92a-3p | BMPR2 | 1.88 | 1.0E-5 | -1.13 | 0.00109 | miRNAWalker2 validate; miRNATAP | -0.2 | 1.0E-5 | NA | |
95 | hsa-miR-93-3p | BMPR2 | 2.63 | 0 | -1.13 | 0.00109 | miRNAWalker2 validate | -0.11 | 0.00334 | NA | |
96 | hsa-miR-93-5p | BMPR2 | 2.66 | 0 | -1.13 | 0.00109 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.13 | 0.00184 | NA | |
97 | hsa-miR-103a-3p | CD274 | 0.99 | 0.00468 | 2.22 | 0.05161 | miRNAWalker2 validate | -0.48 | 0.01013 | NA | |
98 | hsa-miR-106a-5p | CD274 | 3.99 | 0 | 2.22 | 0.05161 | MirTarget; miRNATAP | -0.24 | 0.00245 | NA | |
99 | hsa-miR-182-5p | CD274 | 5.87 | 0 | 2.22 | 0.05161 | mirMAP | -0.34 | 5.0E-5 | NA | |
100 | hsa-miR-200a-3p | CD274 | 6.34 | 0 | 2.22 | 0.05161 | MirTarget | -0.35 | 1.0E-5 | NA | |
101 | hsa-miR-20b-5p | CD274 | 4.57 | 5.0E-5 | 2.22 | 0.05161 | MirTarget; miRNATAP | -0.19 | 0.0007 | 24468585 | These findings suggest that miR-20b -21 and -130b up-regulated in colorectal cancer through inhibiting the expression of PTEN result in B7-H1 over-expression in colorectal cancer |
102 | hsa-miR-324-5p | CD274 | 1.31 | 0.01168 | 2.22 | 0.05161 | miRanda | -0.47 | 0.00014 | NA | |
103 | hsa-miR-429 | CD274 | 6.4 | 0 | 2.22 | 0.05161 | miRanda | -0.41 | 0 | NA | |
104 | hsa-miR-497-5p | CD274 | -1.44 | 0.02251 | 2.22 | 0.05161 | MirTarget | -0.38 | 0.00018 | NA | |
105 | hsa-miR-93-5p | CD274 | 2.66 | 0 | 2.22 | 0.05161 | MirTarget; miRNATAP | -0.46 | 0.00064 | NA | |
106 | hsa-miR-107 | CDKN2B | 1.49 | 0.00013 | 3.05 | 0.00021 | PITA | -0.45 | 0.00018 | NA | |
107 | hsa-miR-125a-3p | CDKN2B | -0.07 | 0.92074 | 3.05 | 0.00021 | miRanda | -0.28 | 1.0E-5 | NA | |
108 | hsa-miR-125a-5p | CDKN2B | -1.32 | 0.00714 | 3.05 | 0.00021 | miRanda | -0.61 | 0 | NA | |
109 | hsa-miR-126-5p | CDKN2B | -0.42 | 0.32997 | 3.05 | 0.00021 | mirMAP | -0.38 | 0.00047 | NA | |
110 | hsa-miR-19a-3p | CDKN2B | 2.17 | 0.00122 | 3.05 | 0.00021 | mirMAP | -0.14 | 0.04376 | NA | |
111 | hsa-miR-19b-3p | CDKN2B | 1.68 | 0.00086 | 3.05 | 0.00021 | mirMAP | -0.21 | 0.02389 | NA | |
112 | hsa-miR-217 | CDKN2B | -0.38 | 0.71741 | 3.05 | 0.00021 | miRanda | -0.15 | 0.00119 | NA | |
113 | hsa-miR-28-5p | CDKN2B | -0.82 | 0.02212 | 3.05 | 0.00021 | miRanda | -0.81 | 0 | NA | |
114 | hsa-miR-335-3p | CDKN2B | 1.2 | 0.09389 | 3.05 | 0.00021 | mirMAP | -0.23 | 0.00046 | NA | |
115 | hsa-miR-374b-5p | CDKN2B | -0.11 | 0.76489 | 3.05 | 0.00021 | miRNAWalker2 validate | -0.43 | 0.00059 | NA | |
116 | hsa-miR-375 | CDKN2B | 3.38 | 0.04499 | 3.05 | 0.00021 | miRNAWalker2 validate; miRNATAP | -0.14 | 0 | NA | |
117 | hsa-miR-450b-5p | CDKN2B | 0.45 | 0.41602 | 3.05 | 0.00021 | mirMAP | -0.27 | 0.00178 | NA | |
118 | hsa-miR-495-3p | CDKN2B | -1.28 | 0.09795 | 3.05 | 0.00021 | MirTarget | -0.18 | 0.00349 | NA | |
119 | hsa-miR-501-3p | CDKN2B | 1.72 | 0.00759 | 3.05 | 0.00021 | PITA | -0.38 | 0 | NA | |
120 | hsa-miR-501-5p | CDKN2B | 1.04 | 0.07772 | 3.05 | 0.00021 | mirMAP | -0.35 | 1.0E-5 | NA | |
121 | hsa-miR-502-3p | CDKN2B | -0.1 | 0.80889 | 3.05 | 0.00021 | PITA | -0.5 | 1.0E-5 | NA | |
122 | hsa-miR-576-5p | CDKN2B | 1.3 | 0.00649 | 3.05 | 0.00021 | MirTarget | -0.24 | 0.01358 | NA | |
123 | hsa-miR-582-5p | CDKN2B | 0.69 | 0.44776 | 3.05 | 0.00021 | miRNATAP | -0.14 | 0.00622 | NA | |
124 | hsa-miR-671-5p | CDKN2B | 1.49 | 0.00687 | 3.05 | 0.00021 | PITA | -0.35 | 3.0E-5 | NA | |
125 | hsa-miR-7-1-3p | CDKN2B | 1.43 | 0.00471 | 3.05 | 0.00021 | MirTarget | -0.36 | 0.00011 | NA | |
126 | hsa-let-7f-5p | CHRD | 0.97 | 0.02403 | -4.87 | 0 | MirTarget; miRNATAP | -0.34 | 0.01715 | NA | |
127 | hsa-let-7g-3p | CHRD | 2.1 | 5.0E-5 | -4.87 | 0 | MirTarget | -0.24 | 0.03692 | NA | |
128 | hsa-miR-21-3p | CREBBP | 3.5 | 0 | -0.4 | 0.18067 | MirTarget | -0.14 | 0 | NA | |
129 | hsa-miR-590-3p | CREBBP | 2.35 | 0 | -0.4 | 0.18067 | PITA; miRanda; mirMAP; miRNATAP | -0.1 | 0.00219 | NA | |
130 | hsa-let-7d-5p | DCN | 0.83 | 0.0127 | -5.58 | 0 | MirTarget | -0.69 | 0.00017 | NA | |
131 | hsa-let-7g-5p | DCN | 0.86 | 0.00648 | -5.58 | 0 | MirTarget | -0.51 | 0.00996 | NA | |
132 | hsa-miR-3065-5p | DCN | 2.14 | 0.06094 | -5.58 | 0 | mirMAP | -0.14 | 0.03582 | NA | |
133 | hsa-miR-374b-3p | DCN | 0.5 | 0.34334 | -5.58 | 0 | MirTarget | -0.28 | 0.01477 | NA | |
134 | hsa-miR-421 | DCN | 1.98 | 0.00092 | -5.58 | 0 | miRanda | -0.28 | 0.00668 | NA | |
135 | hsa-miR-501-5p | DCN | 1.04 | 0.07772 | -5.58 | 0 | mirMAP | -0.36 | 0.00054 | NA | |
136 | hsa-miR-590-3p | DCN | 2.35 | 0 | -5.58 | 0 | MirTarget; PITA; miRanda; mirMAP | -0.42 | 0.00046 | NA | |
137 | hsa-miR-7-1-3p | DCN | 1.43 | 0.00471 | -5.58 | 0 | mirMAP | -0.33 | 0.00582 | NA | |
138 | hsa-let-7a-5p | E2F5 | 0.15 | 0.64531 | -0.64 | 0.41617 | MirTarget; TargetScan; miRNATAP | -0.33 | 0.02249 | NA | |
139 | hsa-let-7b-5p | E2F5 | -0.19 | 0.65188 | -0.64 | 0.41617 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.28 | 0.01021 | NA | |
140 | hsa-let-7f-5p | E2F5 | 0.97 | 0.02403 | -0.64 | 0.41617 | MirTarget; miRNATAP | -0.35 | 0.00066 | NA | |
141 | hsa-let-7i-5p | E2F5 | 0.05 | 0.86971 | -0.64 | 0.41617 | MirTarget; miRNATAP | -0.49 | 0.00194 | NA | |
142 | hsa-miR-1-3p | E2F5 | -3.85 | 1.0E-5 | -0.64 | 0.41617 | MirTarget | -0.15 | 0.00306 | NA | |
143 | hsa-miR-142-3p | E2F5 | 4.35 | 0 | -0.64 | 0.41617 | miRanda | -0.17 | 0.00689 | NA | |
144 | hsa-miR-199b-5p | E2F5 | -0.54 | 0.47689 | -0.64 | 0.41617 | miRanda | -0.13 | 0.03312 | NA | |
145 | hsa-miR-205-5p | E2F5 | 8.08 | 0 | -0.64 | 0.41617 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.18 | 0 | 21454583 | The expression levels of E2F1 and E2F5 were correlated inversely with that of miR-205 in melanoma cell lines; miR-205 significantly suppressed the luciferase activity of reporter plasmids containing the 3'-UTR sequences complementary to either E2F1 or E2F5; Overexpression of miR-205 in melanoma cells reduced E2F1 and E2F5 protein levels |
146 | hsa-miR-34c-5p | E2F5 | 2.65 | 0.01574 | -0.64 | 0.41617 | MirTarget; PITA; miRanda; miRNATAP | -0.16 | 9.0E-5 | NA | |
147 | hsa-miR-148a-3p | EP300 | 1.1 | 0.05204 | 0.22 | 0.57893 | miRNATAP | -0.1 | 0.00975 | NA | |
148 | hsa-miR-26b-5p | EP300 | 0.31 | 0.46163 | 0.22 | 0.57893 | miRNAWalker2 validate; miRNATAP | -0.13 | 0.01396 | NA | |
149 | hsa-miR-30c-5p | EP300 | 0.39 | 0.34861 | 0.22 | 0.57893 | miRNAWalker2 validate | -0.19 | 0.0009 | NA | |
150 | hsa-miR-339-5p | EP300 | 1.23 | 0.03075 | 0.22 | 0.57893 | miRanda | -0.2 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 36 | 190 | 9.482e-57 | 4.412e-53 |
2 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 31 | 207 | 7.085e-45 | 1.648e-41 |
3 | RESPONSE TO GROWTH FACTOR | 36 | 475 | 1.184e-41 | 1.837e-38 |
4 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 39 | 689 | 1.34e-40 | 1.559e-37 |
5 | REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 21 | 60 | 1.1e-38 | 1.023e-35 |
6 | RESPONSE TO BMP | 23 | 94 | 3.037e-38 | 2.018e-35 |
7 | CELLULAR RESPONSE TO BMP STIMULUS | 23 | 94 | 3.037e-38 | 2.018e-35 |
8 | POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 22 | 100 | 2.055e-35 | 1.195e-32 |
9 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 39 | 1008 | 3.475e-34 | 1.797e-31 |
10 | POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 18 | 48 | 8.381e-34 | 3.899e-31 |
11 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 45 | 1784 | 1.672e-32 | 7.074e-30 |
12 | SMAD PROTEIN SIGNAL TRANSDUCTION | 18 | 56 | 2.391e-32 | 9.272e-30 |
13 | RESPONSE TO ENDOGENOUS STIMULUS | 42 | 1450 | 3.431e-32 | 1.228e-29 |
14 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 19 | 95 | 1.099e-29 | 3.653e-27 |
15 | REGULATION OF OSSIFICATION | 22 | 178 | 1.771e-29 | 5.493e-27 |
16 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 19 | 112 | 3.299e-28 | 9.595e-26 |
17 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 42 | 1848 | 6.382e-28 | 1.747e-25 |
18 | POSITIVE REGULATION OF GENE EXPRESSION | 41 | 1733 | 9.08e-28 | 2.347e-25 |
19 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 39 | 1618 | 2.092e-26 | 5.122e-24 |
20 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 19 | 144 | 5.311e-26 | 1.236e-23 |
21 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 39 | 1672 | 7.092e-26 | 1.571e-23 |
22 | ORGAN MORPHOGENESIS | 31 | 841 | 1.104e-25 | 2.335e-23 |
23 | TUBE DEVELOPMENT | 27 | 552 | 2.336e-25 | 4.726e-23 |
24 | TISSUE DEVELOPMENT | 37 | 1518 | 5.931e-25 | 1.15e-22 |
25 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 39 | 1805 | 1.207e-24 | 2.16e-22 |
26 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 32 | 1004 | 1.205e-24 | 2.16e-22 |
27 | REGULATION OF PROTEIN MODIFICATION PROCESS | 38 | 1710 | 2.587e-24 | 4.459e-22 |
28 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 35 | 1395 | 8.629e-24 | 1.434e-21 |
29 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 31 | 983 | 1.182e-23 | 1.897e-21 |
30 | SKELETAL SYSTEM DEVELOPMENT | 24 | 455 | 3.403e-23 | 5.278e-21 |
31 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 32 | 1142 | 6.254e-23 | 9.387e-21 |
32 | REGULATION OF CELL DIFFERENTIATION | 35 | 1492 | 8.017e-23 | 1.166e-20 |
33 | POSITIVE REGULATION OF OSSIFICATION | 15 | 84 | 1.048e-22 | 1.477e-20 |
34 | ACTIVIN RECEPTOR SIGNALING PATHWAY | 11 | 22 | 1.201e-22 | 1.643e-20 |
35 | EPITHELIUM DEVELOPMENT | 29 | 945 | 1.17e-21 | 1.512e-19 |
36 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 34 | 1492 | 1.152e-21 | 1.512e-19 |
37 | PATTERN SPECIFICATION PROCESS | 22 | 418 | 3.395e-21 | 4.27e-19 |
38 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 27 | 801 | 4.148e-21 | 5.079e-19 |
39 | EMBRYO DEVELOPMENT | 28 | 894 | 4.341e-21 | 5.179e-19 |
40 | REGULATION OF CELL DEATH | 33 | 1472 | 1.027e-20 | 1.194e-18 |
41 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 30 | 1135 | 1.266e-20 | 1.437e-18 |
42 | REGULATION OF CELL PROLIFERATION | 33 | 1496 | 1.692e-20 | 1.875e-18 |
43 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 18 | 229 | 1.803e-20 | 1.951e-18 |
44 | HEART DEVELOPMENT | 22 | 466 | 3.559e-20 | 3.761e-18 |
45 | CONNECTIVE TISSUE DEVELOPMENT | 17 | 194 | 3.637e-20 | 3.761e-18 |
46 | GROWTH | 21 | 410 | 5.623e-20 | 5.688e-18 |
47 | UROGENITAL SYSTEM DEVELOPMENT | 19 | 299 | 7.782e-20 | 7.704e-18 |
48 | NEGATIVE REGULATION OF CELL PROLIFERATION | 24 | 643 | 1.125e-19 | 1.09e-17 |
49 | POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 11 | 38 | 1.969e-19 | 1.869e-17 |
50 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 28 | 1036 | 2.19e-19 | 1.998e-17 |
51 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 28 | 1036 | 2.19e-19 | 1.998e-17 |
52 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 35 | 1929 | 3.524e-19 | 3.154e-17 |
53 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 12 | 60 | 5.879e-19 | 5.161e-17 |
54 | CELL DEVELOPMENT | 31 | 1426 | 6.458e-19 | 5.565e-17 |
55 | CARTILAGE DEVELOPMENT | 15 | 147 | 7.202e-19 | 6.093e-17 |
56 | MESODERM DEVELOPMENT | 14 | 118 | 1.327e-18 | 1.102e-16 |
57 | GASTRULATION | 15 | 155 | 1.628e-18 | 1.329e-16 |
58 | MESONEPHROS DEVELOPMENT | 13 | 90 | 1.709e-18 | 1.371e-16 |
59 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 25 | 823 | 2.186e-18 | 1.724e-16 |
60 | POSITIVE REGULATION OF CELL COMMUNICATION | 31 | 1532 | 5.057e-18 | 3.922e-16 |
61 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 13 | 102 | 9.447e-18 | 7.206e-16 |
62 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 24 | 788 | 1.196e-17 | 8.83e-16 |
63 | CIRCULATORY SYSTEM DEVELOPMENT | 24 | 788 | 1.196e-17 | 8.83e-16 |
64 | EMBRYONIC MORPHOGENESIS | 21 | 539 | 1.512e-17 | 1.099e-15 |
65 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 26 | 1021 | 2.783e-17 | 1.992e-15 |
66 | REGULATION OF CELL DEVELOPMENT | 24 | 836 | 4.573e-17 | 3.224e-15 |
67 | PROTEIN PHOSPHORYLATION | 25 | 944 | 5.549e-17 | 3.854e-15 |
68 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 13 | 121 | 9.465e-17 | 6.477e-15 |
69 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 23 | 771 | 1.072e-16 | 7.226e-15 |
70 | KIDNEY EPITHELIUM DEVELOPMENT | 13 | 125 | 1.463e-16 | 9.723e-15 |
71 | MESODERM MORPHOGENESIS | 11 | 66 | 1.639e-16 | 1.074e-14 |
72 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 12 | 99 | 3.529e-16 | 2.249e-14 |
73 | REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 12 | 99 | 3.529e-16 | 2.249e-14 |
74 | REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 11 | 75 | 7.31e-16 | 4.597e-14 |
75 | NEGATIVE REGULATION OF CELL COMMUNICATION | 26 | 1192 | 1.164e-15 | 7.224e-14 |
76 | REGIONALIZATION | 16 | 311 | 2.593e-15 | 1.587e-13 |
77 | TISSUE MORPHOGENESIS | 19 | 533 | 3.528e-15 | 2.132e-13 |
78 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 23 | 917 | 4.494e-15 | 2.681e-13 |
79 | PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 7 | 13 | 4.638e-15 | 2.732e-13 |
80 | GLAND DEVELOPMENT | 17 | 395 | 5.91e-15 | 3.438e-13 |
81 | REGULATION OF CARTILAGE DEVELOPMENT | 10 | 63 | 7.115e-15 | 4.087e-13 |
82 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 21 | 740 | 8.477e-15 | 4.81e-13 |
83 | EMBRYONIC ORGAN DEVELOPMENT | 17 | 406 | 9.28e-15 | 5.202e-13 |
84 | PHOSPHORYLATION | 25 | 1228 | 2.414e-14 | 1.337e-12 |
85 | RHYTHMIC PROCESS | 15 | 298 | 2.959e-14 | 1.62e-12 |
86 | POSITIVE REGULATION OF CELL DEATH | 19 | 605 | 3.467e-14 | 1.876e-12 |
87 | MESENCHYME DEVELOPMENT | 13 | 190 | 3.62e-14 | 1.936e-12 |
88 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 19 | 609 | 3.902e-14 | 2.063e-12 |
89 | POSITIVE REGULATION OF CELL PROLIFERATION | 21 | 814 | 5.483e-14 | 2.866e-12 |
90 | FORMATION OF PRIMARY GERM LAYER | 11 | 110 | 5.833e-14 | 3.015e-12 |
91 | REGULATION OF BMP SIGNALING PATHWAY | 10 | 77 | 5.897e-14 | 3.015e-12 |
92 | SKELETAL SYSTEM MORPHOGENESIS | 13 | 201 | 7.499e-14 | 3.793e-12 |
93 | BONE DEVELOPMENT | 12 | 156 | 9.324e-14 | 4.665e-12 |
94 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 22 | 957 | 1.221e-13 | 6.045e-12 |
95 | POSITIVE REGULATION OF LOCOMOTION | 16 | 420 | 2.726e-13 | 1.335e-11 |
96 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 14 | 285 | 3.294e-13 | 1.597e-11 |
97 | MESENCHYMAL CELL DIFFERENTIATION | 11 | 134 | 5.298e-13 | 2.541e-11 |
98 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 9 | 66 | 7.275e-13 | 3.419e-11 |
99 | NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 9 | 66 | 7.275e-13 | 3.419e-11 |
100 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 67 | 8.382e-13 | 3.9e-11 |
101 | REGULATION OF CELL CYCLE | 21 | 949 | 1.063e-12 | 4.897e-11 |
102 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 12 | 194 | 1.267e-12 | 5.779e-11 |
103 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 16 | 465 | 1.286e-12 | 5.808e-11 |
104 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 17 | 554 | 1.423e-12 | 6.369e-11 |
105 | ODONTOGENESIS | 10 | 105 | 1.445e-12 | 6.405e-11 |
106 | RESPIRATORY SYSTEM DEVELOPMENT | 12 | 197 | 1.52e-12 | 6.672e-11 |
107 | DIGESTIVE SYSTEM DEVELOPMENT | 11 | 148 | 1.59e-12 | 6.915e-11 |
108 | NEGATIVE REGULATION OF GENE EXPRESSION | 25 | 1493 | 1.938e-12 | 8.349e-11 |
109 | REGULATION OF MAPK CASCADE | 18 | 660 | 2.005e-12 | 8.557e-11 |
110 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 25 | 1517 | 2.756e-12 | 1.166e-10 |
111 | RESPONSE TO LIPID | 20 | 888 | 3.061e-12 | 1.272e-10 |
112 | REGULATION OF STEM CELL DIFFERENTIATION | 10 | 113 | 3.049e-12 | 1.272e-10 |
113 | HEART MORPHOGENESIS | 12 | 212 | 3.622e-12 | 1.491e-10 |
114 | POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 7 | 29 | 4.05e-12 | 1.653e-10 |
115 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 22 | 1152 | 4.942e-12 | 2e-10 |
116 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 17 | 602 | 5.334e-12 | 2.14e-10 |
117 | REGULATION OF BINDING | 13 | 283 | 5.895e-12 | 2.344e-10 |
118 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 7 | 34 | 1.378e-11 | 5.435e-10 |
119 | REGULATION OF ORGAN MORPHOGENESIS | 12 | 242 | 1.714e-11 | 6.7e-10 |
120 | POSITIVE REGULATION OF CELL DEVELOPMENT | 15 | 472 | 2.213e-11 | 8.582e-10 |
121 | STEM CELL DIFFERENTIATION | 11 | 190 | 2.436e-11 | 9.367e-10 |
122 | OSSIFICATION | 12 | 251 | 2.624e-11 | 1.001e-09 |
123 | TUBE MORPHOGENESIS | 13 | 323 | 3.088e-11 | 1.168e-09 |
124 | MESENCHYME MORPHOGENESIS | 7 | 38 | 3.201e-11 | 1.201e-09 |
125 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 14 | 404 | 3.602e-11 | 1.341e-09 |
126 | SENSORY ORGAN DEVELOPMENT | 15 | 493 | 4.083e-11 | 1.508e-09 |
127 | NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 7 | 40 | 4.704e-11 | 1.724e-09 |
128 | NEGATIVE REGULATION OF OSSIFICATION | 8 | 69 | 5.701e-11 | 2.073e-09 |
129 | HEAD DEVELOPMENT | 17 | 709 | 6.945e-11 | 2.505e-09 |
130 | EMBRYONIC ORGAN MORPHOGENESIS | 12 | 279 | 8.951e-11 | 3.197e-09 |
131 | NEGATIVE REGULATION OF CELL CYCLE | 14 | 433 | 9e-11 | 3.197e-09 |
132 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 20 | 1087 | 1.164e-10 | 4.103e-09 |
133 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 22 | 1360 | 1.249e-10 | 4.37e-09 |
134 | REGULATION OF APOPTOTIC SIGNALING PATHWAY | 13 | 363 | 1.313e-10 | 4.559e-09 |
135 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 26 | 1977 | 1.369e-10 | 4.718e-09 |
136 | REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 6 | 25 | 1.57e-10 | 5.37e-09 |
137 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 22 | 1381 | 1.676e-10 | 5.691e-09 |
138 | NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 8 | 80 | 1.922e-10 | 6.481e-09 |
139 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 9 | 122 | 2.081e-10 | 6.965e-09 |
140 | NEUROGENESIS | 22 | 1402 | 2.236e-10 | 7.431e-09 |
141 | POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS | 5 | 12 | 2.412e-10 | 7.959e-09 |
142 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 7 | 50 | 2.457e-10 | 8.052e-09 |
143 | VASCULATURE DEVELOPMENT | 14 | 469 | 2.565e-10 | 8.347e-09 |
144 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 6 | 27 | 2.61e-10 | 8.434e-09 |
145 | CARDIAC SEPTUM DEVELOPMENT | 8 | 85 | 3.151e-10 | 9.973e-09 |
146 | PALATE DEVELOPMENT | 8 | 85 | 3.151e-10 | 9.973e-09 |
147 | IN UTERO EMBRYONIC DEVELOPMENT | 12 | 311 | 3.121e-10 | 9.973e-09 |
148 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 9 | 129 | 3.434e-10 | 1.08e-08 |
149 | REPRODUCTION | 21 | 1297 | 3.698e-10 | 1.155e-08 |
150 | IMMUNE SYSTEM DEVELOPMENT | 15 | 582 | 4.111e-10 | 1.275e-08 |
151 | REPRODUCTIVE SYSTEM DEVELOPMENT | 13 | 408 | 5.504e-10 | 1.696e-08 |
152 | EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 8 | 93 | 6.534e-10 | 2e-08 |
153 | EMBRYONIC PATTERN SPECIFICATION | 7 | 58 | 7.248e-10 | 2.204e-08 |
154 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 12 | 337 | 7.798e-10 | 2.356e-08 |
155 | ENDOCARDIAL CUSHION DEVELOPMENT | 6 | 32 | 7.89e-10 | 2.369e-08 |
156 | GLAND MORPHOGENESIS | 8 | 97 | 9.178e-10 | 2.738e-08 |
157 | HEART VALVE DEVELOPMENT | 6 | 34 | 1.165e-09 | 3.453e-08 |
158 | REGULATION OF EPIDERMIS DEVELOPMENT | 7 | 63 | 1.317e-09 | 3.854e-08 |
159 | REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS | 5 | 16 | 1.317e-09 | 3.854e-08 |
160 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 9 | 153 | 1.571e-09 | 4.569e-08 |
161 | POSITIVE REGULATION OF PROTEIN IMPORT | 8 | 104 | 1.607e-09 | 4.644e-08 |
162 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 14 | 541 | 1.633e-09 | 4.662e-08 |
163 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 14 | 541 | 1.633e-09 | 4.662e-08 |
164 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 9 | 154 | 1.664e-09 | 4.722e-08 |
165 | CELL DEATH | 18 | 1001 | 1.783e-09 | 5.029e-08 |
166 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 10 | 218 | 2.043e-09 | 5.728e-08 |
167 | RESPONSE TO HORMONE | 17 | 893 | 2.373e-09 | 6.612e-08 |
168 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 9 | 162 | 2.604e-09 | 7.212e-08 |
169 | CELL PROLIFERATION | 15 | 672 | 2.934e-09 | 8.078e-08 |
170 | CELL FATE COMMITMENT | 10 | 227 | 3.019e-09 | 8.263e-08 |
171 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 9 | 167 | 3.404e-09 | 9.261e-08 |
172 | APPENDAGE DEVELOPMENT | 9 | 169 | 3.779e-09 | 1.016e-07 |
173 | LIMB DEVELOPMENT | 9 | 169 | 3.779e-09 | 1.016e-07 |
174 | REGULATION OF VASCULATURE DEVELOPMENT | 10 | 233 | 3.88e-09 | 1.038e-07 |
175 | POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 9 | 171 | 4.191e-09 | 1.114e-07 |
176 | NEGATIVE REGULATION OF GROWTH | 10 | 236 | 4.388e-09 | 1.16e-07 |
177 | ARTERY DEVELOPMENT | 7 | 75 | 4.582e-09 | 1.205e-07 |
178 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 22 | 1656 | 5.108e-09 | 1.335e-07 |
179 | MORPHOGENESIS OF AN EPITHELIUM | 12 | 400 | 5.383e-09 | 1.392e-07 |
180 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 8 | 121 | 5.376e-09 | 1.392e-07 |
181 | EPITHELIAL CELL DIFFERENTIATION | 13 | 495 | 5.677e-09 | 1.459e-07 |
182 | RESPONSE TO STEROID HORMONE | 13 | 497 | 5.957e-09 | 1.523e-07 |
183 | ENDOCRINE SYSTEM DEVELOPMENT | 8 | 123 | 6.122e-09 | 1.557e-07 |
184 | LUNG MORPHOGENESIS | 6 | 45 | 6.862e-09 | 1.735e-07 |
185 | EYE DEVELOPMENT | 11 | 326 | 7.453e-09 | 1.875e-07 |
186 | REGULATION OF PROTEIN IMPORT | 9 | 183 | 7.593e-09 | 1.899e-07 |
187 | EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 6 | 46 | 7.872e-09 | 1.959e-07 |
188 | REGULATION OF PHOSPHATASE ACTIVITY | 8 | 128 | 8.392e-09 | 2.077e-07 |
189 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 13 | 513 | 8.689e-09 | 2.139e-07 |
190 | DEVELOPMENTAL GROWTH | 11 | 333 | 9.286e-09 | 2.274e-07 |
191 | LOCOMOTION | 18 | 1114 | 9.548e-09 | 2.326e-07 |
192 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 8 | 131 | 1.008e-08 | 2.442e-07 |
193 | DIGESTIVE TRACT MORPHOGENESIS | 6 | 48 | 1.026e-08 | 2.474e-07 |
194 | REGULATION OF CELL ADHESION | 14 | 629 | 1.114e-08 | 2.671e-07 |
195 | REGULATION OF GROWTH | 14 | 633 | 1.206e-08 | 2.878e-07 |
196 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 15 | 750 | 1.283e-08 | 3.045e-07 |
197 | NEGATIVE REGULATION OF CELL DEATH | 16 | 872 | 1.296e-08 | 3.045e-07 |
198 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 16 | 872 | 1.296e-08 | 3.045e-07 |
199 | SEX DIFFERENTIATION | 10 | 266 | 1.376e-08 | 3.218e-07 |
200 | OVULATION CYCLE PROCESS | 7 | 88 | 1.418e-08 | 3.299e-07 |
201 | DORSAL VENTRAL PATTERN FORMATION | 7 | 91 | 1.794e-08 | 4.153e-07 |
202 | RESPONSE TO ABIOTIC STIMULUS | 17 | 1024 | 1.821e-08 | 4.195e-07 |
203 | MUSCLE TISSUE DEVELOPMENT | 10 | 275 | 1.887e-08 | 4.326e-07 |
204 | REGULATION OF KINASE ACTIVITY | 15 | 776 | 2.019e-08 | 4.605e-07 |
205 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 11 | 360 | 2.072e-08 | 4.68e-07 |
206 | REGULATION OF CELL MORPHOGENESIS | 13 | 552 | 2.069e-08 | 4.68e-07 |
207 | CARDIAC CHAMBER DEVELOPMENT | 8 | 144 | 2.12e-08 | 4.766e-07 |
208 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 10 | 279 | 2.164e-08 | 4.841e-07 |
209 | REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 5 | 27 | 2.368e-08 | 5.271e-07 |
210 | CRANIAL SKELETAL SYSTEM DEVELOPMENT | 6 | 55 | 2.381e-08 | 5.276e-07 |
211 | EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 56 | 2.66e-08 | 5.867e-07 |
212 | GASTRULATION WITH MOUTH FORMING SECOND | 5 | 28 | 2.875e-08 | 6.311e-07 |
213 | REGULATION OF HEART MORPHOGENESIS | 5 | 29 | 3.466e-08 | 7.571e-07 |
214 | CELL CYCLE ARREST | 8 | 154 | 3.583e-08 | 7.791e-07 |
215 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 9 | 220 | 3.752e-08 | 8.119e-07 |
216 | PROTEIN LOCALIZATION TO NUCLEUS | 8 | 156 | 3.962e-08 | 8.535e-07 |
217 | REGULATION OF TRANSFERASE ACTIVITY | 16 | 946 | 4.04e-08 | 8.663e-07 |
218 | CHONDROCYTE DIFFERENTIATION | 6 | 60 | 4.061e-08 | 8.667e-07 |
219 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 7 | 103 | 4.26e-08 | 9.05e-07 |
220 | REGULATION OF PROTEIN LOCALIZATION | 16 | 950 | 4.284e-08 | 9.06e-07 |
221 | REGULATION OF DEPHOSPHORYLATION | 8 | 158 | 4.375e-08 | 9.212e-07 |
222 | REGULATION OF EPITHELIAL CELL MIGRATION | 8 | 166 | 6.421e-08 | 1.346e-06 |
223 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 13 | 616 | 7.465e-08 | 1.558e-06 |
224 | REGULATION OF CELLULAR LOCALIZATION | 18 | 1277 | 7.751e-08 | 1.61e-06 |
225 | ORGAN FORMATION | 5 | 34 | 8.019e-08 | 1.651e-06 |
226 | REGULATION OF MESENCHYMAL CELL PROLIFERATION | 5 | 34 | 8.019e-08 | 1.651e-06 |
227 | OVULATION CYCLE | 7 | 113 | 8.095e-08 | 1.659e-06 |
228 | POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 12 | 514 | 8.532e-08 | 1.741e-06 |
229 | ORGAN GROWTH | 6 | 68 | 8.7e-08 | 1.768e-06 |
230 | NEURON DIFFERENTIATION | 15 | 874 | 9.629e-08 | 1.948e-06 |
231 | SPECIFICATION OF SYMMETRY | 7 | 117 | 1.029e-07 | 2.073e-06 |
232 | ENDODERM DEVELOPMENT | 6 | 71 | 1.13e-07 | 2.266e-06 |
233 | CELL CYCLE | 18 | 1316 | 1.22e-07 | 2.436e-06 |
234 | REGULATION OF TRANSPORT | 21 | 1804 | 1.264e-07 | 2.512e-06 |
235 | MULTICELLULAR ORGANISM REPRODUCTION | 14 | 768 | 1.333e-07 | 2.639e-06 |
236 | REGULATION OF HAIR FOLLICLE DEVELOPMENT | 4 | 15 | 1.35e-07 | 2.661e-06 |
237 | ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 6 | 75 | 1.572e-07 | 3.087e-06 |
238 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 9 | 262 | 1.669e-07 | 3.264e-06 |
239 | OSTEOBLAST DIFFERENTIATION | 7 | 126 | 1.712e-07 | 3.333e-06 |
240 | MYELOID CELL DIFFERENTIATION | 8 | 189 | 1.747e-07 | 3.387e-06 |
241 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 12 | 552 | 1.843e-07 | 3.559e-06 |
242 | REGULATION OF HOMEOSTATIC PROCESS | 11 | 447 | 1.857e-07 | 3.571e-06 |
243 | REGULATION OF NEURON DIFFERENTIATION | 12 | 554 | 1.916e-07 | 3.669e-06 |
244 | BONE MORPHOGENESIS | 6 | 79 | 2.149e-07 | 4.098e-06 |
245 | REGULATION OF CYTOKINE PRODUCTION | 12 | 563 | 2.278e-07 | 4.326e-06 |
246 | PITUITARY GLAND DEVELOPMENT | 5 | 42 | 2.403e-07 | 4.527e-06 |
247 | NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 5 | 42 | 2.403e-07 | 4.527e-06 |
248 | CELL CYCLE PROCESS | 16 | 1081 | 2.509e-07 | 4.708e-06 |
249 | REGULATION OF IMMUNE SYSTEM PROCESS | 18 | 1403 | 3.168e-07 | 5.92e-06 |
250 | ENDOCHONDRAL BONE MORPHOGENESIS | 5 | 45 | 3.426e-07 | 6.376e-06 |
251 | POSITIVE REGULATION OF CELL ADHESION | 10 | 376 | 3.493e-07 | 6.475e-06 |
252 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 7 | 140 | 3.514e-07 | 6.489e-06 |
253 | ATRIOVENTRICULAR VALVE DEVELOPMENT | 4 | 19 | 3.796e-07 | 6.981e-06 |
254 | REGULATION OF CHONDROCYTE DIFFERENTIATION | 5 | 46 | 3.834e-07 | 7.023e-06 |
255 | NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 8 | 211 | 4.049e-07 | 7.389e-06 |
256 | EPITHELIAL CELL PROLIFERATION | 6 | 89 | 4.38e-07 | 7.961e-06 |
257 | AXIS SPECIFICATION | 6 | 90 | 4.681e-07 | 8.442e-06 |
258 | ENDOTHELIUM DEVELOPMENT | 6 | 90 | 4.681e-07 | 8.442e-06 |
259 | NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 4 | 20 | 4.733e-07 | 8.503e-06 |
260 | DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 8 | 216 | 4.837e-07 | 8.657e-06 |
261 | MALE SEX DIFFERENTIATION | 7 | 148 | 5.124e-07 | 9.134e-06 |
262 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 9 | 303 | 5.674e-07 | 1.008e-05 |
263 | IMMUNE SYSTEM PROCESS | 21 | 1984 | 6.237e-07 | 1.103e-05 |
264 | REGULATION OF PROTEIN TARGETING | 9 | 307 | 6.331e-07 | 1.116e-05 |
265 | CARDIOCYTE DIFFERENTIATION | 6 | 96 | 6.865e-07 | 1.205e-05 |
266 | REGULATION OF HAIR CYCLE | 4 | 22 | 7.111e-07 | 1.23e-05 |
267 | ENDOCARDIAL CUSHION MORPHOGENESIS | 4 | 22 | 7.111e-07 | 1.23e-05 |
268 | RESPONSE TO EXTERNAL STIMULUS | 20 | 1821 | 7.084e-07 | 1.23e-05 |
269 | RESPONSE TO OXYGEN LEVELS | 9 | 311 | 7.052e-07 | 1.23e-05 |
270 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 6 | 98 | 7.755e-07 | 1.336e-05 |
271 | MESONEPHRIC TUBULE MORPHOGENESIS | 5 | 53 | 7.887e-07 | 1.349e-05 |
272 | POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 53 | 7.887e-07 | 1.349e-05 |
273 | VENTRICULAR SEPTUM DEVELOPMENT | 5 | 54 | 8.67e-07 | 1.478e-05 |
274 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 6 | 100 | 8.738e-07 | 1.484e-05 |
275 | CELLULAR COMPONENT MORPHOGENESIS | 14 | 900 | 9.038e-07 | 1.529e-05 |
276 | NEGATIVE REGULATION OF PHOSPHORYLATION | 10 | 422 | 9.994e-07 | 1.685e-05 |
277 | RESPONSE TO STEROL | 4 | 24 | 1.028e-06 | 1.721e-05 |
278 | CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 4 | 24 | 1.028e-06 | 1.721e-05 |
279 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 6 | 103 | 1.04e-06 | 1.729e-05 |
280 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 6 | 103 | 1.04e-06 | 1.729e-05 |
281 | REGULATION OF PROTEIN BINDING | 7 | 168 | 1.203e-06 | 1.985e-05 |
282 | RESPONSE TO CARBOHYDRATE | 7 | 168 | 1.203e-06 | 1.985e-05 |
283 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 4 | 25 | 1.221e-06 | 2.007e-05 |
284 | REGULATION OF GLIAL CELL DIFFERENTIATION | 5 | 59 | 1.355e-06 | 2.221e-05 |
285 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 10 | 437 | 1.37e-06 | 2.236e-05 |
286 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 15 | 1079 | 1.411e-06 | 2.296e-05 |
287 | NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 4 | 26 | 1.439e-06 | 2.317e-05 |
288 | NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 4 | 26 | 1.439e-06 | 2.317e-05 |
289 | POSITIVE REGULATION OF TRANSPORT | 14 | 936 | 1.438e-06 | 2.317e-05 |
290 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 5 | 60 | 1.475e-06 | 2.367e-05 |
291 | CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 8 | 252 | 1.544e-06 | 2.469e-05 |
292 | EMBRYONIC DIGIT MORPHOGENESIS | 5 | 61 | 1.603e-06 | 2.536e-05 |
293 | OVARIAN FOLLICLE DEVELOPMENT | 5 | 61 | 1.603e-06 | 2.536e-05 |
294 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 5 | 61 | 1.603e-06 | 2.536e-05 |
295 | POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 6 | 111 | 1.614e-06 | 2.546e-05 |
296 | REGULATION OF ASTROCYTE DIFFERENTIATION | 4 | 27 | 1.685e-06 | 2.641e-05 |
297 | POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 4 | 27 | 1.685e-06 | 2.641e-05 |
298 | RESPONSE TO WOUNDING | 11 | 563 | 1.802e-06 | 2.813e-05 |
299 | POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 8 | 258 | 1.84e-06 | 2.864e-05 |
300 | NEPHRON DEVELOPMENT | 6 | 115 | 1.986e-06 | 3.08e-05 |
301 | CELLULAR RESPONSE TO LIPID | 10 | 457 | 2.046e-06 | 3.159e-05 |
302 | RESPONSE TO KETONE | 7 | 182 | 2.054e-06 | 3.159e-05 |
303 | REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 9 | 354 | 2.057e-06 | 3.159e-05 |
304 | FEMALE SEX DIFFERENTIATION | 6 | 116 | 2.089e-06 | 3.197e-05 |
305 | FOREBRAIN DEVELOPMENT | 9 | 357 | 2.205e-06 | 3.363e-05 |
306 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 16 | 1275 | 2.241e-06 | 3.407e-05 |
307 | RESPONSE TO ALCOHOL | 9 | 362 | 2.471e-06 | 3.745e-05 |
308 | REGULATION OF MITOTIC CELL CYCLE | 10 | 468 | 2.53e-06 | 3.822e-05 |
309 | NEURON FATE COMMITMENT | 5 | 67 | 2.563e-06 | 3.859e-05 |
310 | BLOOD VESSEL MORPHOGENESIS | 9 | 364 | 2.584e-06 | 3.879e-05 |
311 | REGULATION OF CELL JUNCTION ASSEMBLY | 5 | 68 | 2.759e-06 | 4.115e-05 |
312 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 5 | 68 | 2.759e-06 | 4.115e-05 |
313 | REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 6 | 122 | 2.803e-06 | 4.166e-05 |
314 | POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 9 | 370 | 2.954e-06 | 4.363e-05 |
315 | POSITIVE REGULATION OF SECRETION | 9 | 370 | 2.954e-06 | 4.363e-05 |
316 | REGULATION OF HORMONE LEVELS | 10 | 478 | 3.054e-06 | 4.497e-05 |
317 | NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 9 | 372 | 3.086e-06 | 4.53e-05 |
318 | REGULATION OF CYTOPLASMIC TRANSPORT | 10 | 481 | 3.229e-06 | 4.724e-05 |
319 | POSITIVE REGULATION OF KINASE ACTIVITY | 10 | 482 | 3.289e-06 | 4.797e-05 |
320 | SALIVARY GLAND DEVELOPMENT | 4 | 32 | 3.412e-06 | 4.93e-05 |
321 | POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 4 | 32 | 3.412e-06 | 4.93e-05 |
322 | POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 4 | 32 | 3.412e-06 | 4.93e-05 |
323 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 13 | 867 | 3.538e-06 | 5.097e-05 |
324 | POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 8 | 282 | 3.56e-06 | 5.113e-05 |
325 | ENDOTHELIAL CELL DIFFERENTIATION | 5 | 72 | 3.667e-06 | 5.25e-05 |
326 | NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 7 | 199 | 3.712e-06 | 5.298e-05 |
327 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 9 | 381 | 3.75e-06 | 5.335e-05 |
328 | EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 4 | 33 | 3.873e-06 | 5.48e-05 |
329 | NUCLEAR IMPORT | 6 | 129 | 3.875e-06 | 5.48e-05 |
330 | PROTEIN KINASE B SIGNALING | 4 | 34 | 4.378e-06 | 6.174e-05 |
331 | REGULATION OF PROTEIN SECRETION | 9 | 389 | 4.438e-06 | 6.239e-05 |
332 | NEURAL CREST CELL DIFFERENTIATION | 5 | 75 | 4.49e-06 | 6.292e-05 |
333 | REGULATION OF INTRACELLULAR TRANSPORT | 11 | 621 | 4.621e-06 | 6.456e-05 |
334 | ANGIOGENESIS | 8 | 293 | 4.72e-06 | 6.575e-05 |
335 | MULTI ORGANISM REPRODUCTIVE PROCESS | 13 | 891 | 4.765e-06 | 6.619e-05 |
336 | DIENCEPHALON DEVELOPMENT | 5 | 77 | 5.114e-06 | 7.082e-05 |
337 | POSITIVE REGULATION OF HAIR CYCLE | 3 | 11 | 5.306e-06 | 7.305e-05 |
338 | NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 3 | 11 | 5.306e-06 | 7.305e-05 |
339 | RENAL TUBULE DEVELOPMENT | 5 | 78 | 5.451e-06 | 7.459e-05 |
340 | SOMITE DEVELOPMENT | 5 | 78 | 5.451e-06 | 7.459e-05 |
341 | NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT | 4 | 36 | 5.534e-06 | 7.53e-05 |
342 | NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 4 | 36 | 5.534e-06 | 7.53e-05 |
343 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 12 | 767 | 5.771e-06 | 7.829e-05 |
344 | NEGATIVE REGULATION OF GLIOGENESIS | 4 | 37 | 6.19e-06 | 8.373e-05 |
345 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 9 | 406 | 6.271e-06 | 8.458e-05 |
346 | POSITIVE REGULATION OF HOMEOSTATIC PROCESS | 7 | 216 | 6.364e-06 | 8.559e-05 |
347 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 8 | 306 | 6.489e-06 | 8.701e-05 |
348 | METANEPHROS DEVELOPMENT | 5 | 81 | 6.566e-06 | 8.754e-05 |
349 | POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 5 | 81 | 6.566e-06 | 8.754e-05 |
350 | RESPONSE TO ESTROGEN | 7 | 218 | 6.76e-06 | 8.987e-05 |
351 | KIDNEY MORPHOGENESIS | 5 | 82 | 6.975e-06 | 9.246e-05 |
352 | REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 3 | 12 | 7.059e-06 | 9.252e-05 |
353 | ANATOMICAL STRUCTURE REGRESSION | 3 | 12 | 7.059e-06 | 9.252e-05 |
354 | TRACHEA MORPHOGENESIS | 3 | 12 | 7.059e-06 | 9.252e-05 |
355 | REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER | 3 | 12 | 7.059e-06 | 9.252e-05 |
356 | CELLULAR RESPONSE TO STRESS | 17 | 1565 | 7.091e-06 | 9.268e-05 |
357 | CELLULAR MACROMOLECULE LOCALIZATION | 15 | 1234 | 7.322e-06 | 9.543e-05 |
358 | REGULATION OF HEMOPOIESIS | 8 | 314 | 7.835e-06 | 0.0001018 |
359 | REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 6 | 147 | 8.226e-06 | 0.0001066 |
360 | REGULATION OF MAP KINASE ACTIVITY | 8 | 319 | 8.79e-06 | 0.0001136 |
361 | NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 3 | 13 | 9.155e-06 | 0.0001167 |
362 | REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 3 | 13 | 9.155e-06 | 0.0001167 |
363 | MESENCHYMAL CELL PROLIFERATION | 3 | 13 | 9.155e-06 | 0.0001167 |
364 | REGULATION OF GONADOTROPIN SECRETION | 3 | 13 | 9.155e-06 | 0.0001167 |
365 | REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 3 | 13 | 9.155e-06 | 0.0001167 |
366 | TISSUE REMODELING | 5 | 87 | 9.328e-06 | 0.0001186 |
367 | MYELOID CELL HOMEOSTASIS | 5 | 88 | 9.865e-06 | 0.0001247 |
368 | REGULATION OF STEM CELL PROLIFERATION | 5 | 88 | 9.865e-06 | 0.0001247 |
369 | REGULATION OF LEUKOCYTE DIFFERENTIATION | 7 | 232 | 1.015e-05 | 0.0001279 |
370 | SEGMENTATION | 5 | 89 | 1.043e-05 | 0.0001311 |
371 | REGULATION OF GLIOGENESIS | 5 | 90 | 1.101e-05 | 0.0001381 |
372 | PROTEIN IMPORT | 6 | 155 | 1.114e-05 | 0.0001393 |
373 | POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 3 | 14 | 1.163e-05 | 0.0001431 |
374 | REGULATION OF GLOMERULUS DEVELOPMENT | 3 | 14 | 1.163e-05 | 0.0001431 |
375 | EMBRYONIC SKELETAL JOINT DEVELOPMENT | 3 | 14 | 1.163e-05 | 0.0001431 |
376 | PROTEIN LOCALIZATION TO ORGANELLE | 10 | 556 | 1.152e-05 | 0.0001431 |
377 | PROTEIN LOCALIZATION | 18 | 1805 | 1.163e-05 | 0.0001431 |
378 | RESPONSE TO LAMINAR FLUID SHEAR STRESS | 3 | 14 | 1.163e-05 | 0.0001431 |
379 | POSITIVE REGULATION OF CELL CYCLE | 8 | 332 | 1.175e-05 | 0.0001442 |
380 | POSITIVE REGULATION OF GROWTH | 7 | 238 | 1.198e-05 | 0.0001466 |
381 | RESPONSE TO EXTRACELLULAR STIMULUS | 9 | 441 | 1.216e-05 | 0.0001485 |
382 | BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 4 | 44 | 1.251e-05 | 0.0001524 |
383 | REGULATION OF CELLULAR RESPONSE TO STRESS | 11 | 691 | 1.265e-05 | 0.0001537 |
384 | NEPHRON EPITHELIUM DEVELOPMENT | 5 | 93 | 1.292e-05 | 0.0001566 |
385 | REGULATION OF RESPONSE TO STRESS | 16 | 1468 | 1.353e-05 | 0.0001635 |
386 | REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS | 5 | 94 | 1.362e-05 | 0.0001641 |
387 | EXOCRINE SYSTEM DEVELOPMENT | 4 | 45 | 1.369e-05 | 0.0001647 |
388 | POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 9 | 448 | 1.379e-05 | 0.0001653 |
389 | REGULATION OF SECRETION | 11 | 699 | 1.409e-05 | 0.0001685 |
390 | NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 3 | 15 | 1.45e-05 | 0.0001725 |
391 | VENOUS BLOOD VESSEL DEVELOPMENT | 3 | 15 | 1.45e-05 | 0.0001725 |
392 | POSITIVE REGULATION OF HEMOPOIESIS | 6 | 163 | 1.484e-05 | 0.0001761 |
393 | PEPTIDYL THREONINE MODIFICATION | 4 | 46 | 1.496e-05 | 0.0001767 |
394 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 4 | 46 | 1.496e-05 | 0.0001767 |
395 | HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 5 | 98 | 1.668e-05 | 0.000196 |
396 | NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 98 | 1.668e-05 | 0.000196 |
397 | EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 99 | 1.752e-05 | 0.0002054 |
398 | REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 4 | 48 | 1.775e-05 | 0.0002071 |
399 | PARAXIAL MESODERM DEVELOPMENT | 3 | 16 | 1.78e-05 | 0.0002071 |
400 | ATRIOVENTRICULAR VALVE MORPHOGENESIS | 3 | 16 | 1.78e-05 | 0.0002071 |
401 | RESPONSE TO NITROGEN COMPOUND | 12 | 859 | 1.801e-05 | 0.0002089 |
402 | TAXIS | 9 | 464 | 1.82e-05 | 0.0002107 |
403 | CARDIAC SEPTUM MORPHOGENESIS | 4 | 49 | 1.929e-05 | 0.0002227 |
404 | POSITIVE REGULATION OF MAPK CASCADE | 9 | 470 | 2.014e-05 | 0.0002307 |
405 | WOUND HEALING | 9 | 470 | 2.014e-05 | 0.0002307 |
406 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 9 | 470 | 2.014e-05 | 0.0002307 |
407 | REGULATION OF ORGANELLE ORGANIZATION | 14 | 1178 | 2.018e-05 | 0.0002307 |
408 | GAMETE GENERATION | 10 | 595 | 2.066e-05 | 0.0002356 |
409 | REGULATION OF ADHERENS JUNCTION ORGANIZATION | 4 | 50 | 2.091e-05 | 0.0002373 |
410 | FACE DEVELOPMENT | 4 | 50 | 2.091e-05 | 0.0002373 |
411 | ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 8 | 361 | 2.147e-05 | 0.000243 |
412 | NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 3 | 17 | 2.157e-05 | 0.0002436 |
413 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 12 | 876 | 2.186e-05 | 0.0002463 |
414 | REGULATION OF HORMONE SECRETION | 7 | 262 | 2.226e-05 | 0.0002501 |
415 | POSITIVE REGULATION OF PROTEOLYSIS | 8 | 363 | 2.233e-05 | 0.0002504 |
416 | REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 8 | 365 | 2.323e-05 | 0.0002598 |
417 | REGULATION OF FAT CELL DIFFERENTIATION | 5 | 106 | 2.44e-05 | 0.0002709 |
418 | CARDIAC VENTRICLE DEVELOPMENT | 5 | 106 | 2.44e-05 | 0.0002709 |
419 | FAT CELL DIFFERENTIATION | 5 | 106 | 2.44e-05 | 0.0002709 |
420 | PERICARDIUM DEVELOPMENT | 3 | 18 | 2.582e-05 | 0.0002854 |
421 | KIDNEY MESENCHYME DEVELOPMENT | 3 | 18 | 2.582e-05 | 0.0002854 |
422 | REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 4 | 53 | 2.64e-05 | 0.000291 |
423 | REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 5 | 108 | 2.67e-05 | 0.0002937 |
424 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 10 | 616 | 2.778e-05 | 0.0003049 |
425 | REGULATION OF MYELOID CELL DIFFERENTIATION | 6 | 183 | 2.854e-05 | 0.0003124 |
426 | NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 4 | 55 | 3.059e-05 | 0.000331 |
427 | REGULATION OF KIDNEY DEVELOPMENT | 4 | 55 | 3.059e-05 | 0.000331 |
428 | CELL CYCLE G1 S PHASE TRANSITION | 5 | 111 | 3.047e-05 | 0.000331 |
429 | G1 S TRANSITION OF MITOTIC CELL CYCLE | 5 | 111 | 3.047e-05 | 0.000331 |
430 | POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 3 | 19 | 3.059e-05 | 0.000331 |
431 | REGULATION OF CELL CELL ADHESION | 8 | 380 | 3.095e-05 | 0.0003342 |
432 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 5 | 114 | 3.464e-05 | 0.0003723 |
433 | NOTCH SIGNALING PATHWAY | 5 | 114 | 3.464e-05 | 0.0003723 |
434 | TRACHEA DEVELOPMENT | 3 | 20 | 3.59e-05 | 0.000384 |
435 | DORSAL VENTRAL AXIS SPECIFICATION | 3 | 20 | 3.59e-05 | 0.000384 |
436 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 5 | 115 | 3.613e-05 | 0.0003856 |
437 | REGULATION OF SYSTEM PROCESS | 9 | 507 | 3.647e-05 | 0.0003883 |
438 | REGULATION OF CELL GROWTH | 8 | 391 | 3.789e-05 | 0.0004026 |
439 | MAMMARY GLAND DEVELOPMENT | 5 | 117 | 3.925e-05 | 0.000416 |
440 | REGULATION OF DEVELOPMENTAL GROWTH | 7 | 289 | 4.16e-05 | 0.0004399 |
441 | CHONDROCYTE DEVELOPMENT | 3 | 21 | 4.179e-05 | 0.0004409 |
442 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 6 | 197 | 4.312e-05 | 0.0004529 |
443 | STEM CELL PROLIFERATION | 4 | 60 | 4.321e-05 | 0.0004529 |
444 | REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 4 | 60 | 4.321e-05 | 0.0004529 |
445 | NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 6 | 200 | 4.691e-05 | 0.0004905 |
446 | NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 3 | 22 | 4.828e-05 | 0.0005003 |
447 | POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 3 | 22 | 4.828e-05 | 0.0005003 |
448 | DSRNA FRAGMENTATION | 3 | 22 | 4.828e-05 | 0.0005003 |
449 | PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA | 3 | 22 | 4.828e-05 | 0.0005003 |
450 | SOMITOGENESIS | 4 | 62 | 4.919e-05 | 0.0005087 |
451 | PROTEIN TARGETING | 8 | 406 | 4.942e-05 | 0.0005099 |
452 | NEURON PROJECTION GUIDANCE | 6 | 205 | 5.382e-05 | 0.000554 |
453 | POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 3 | 23 | 5.539e-05 | 0.0005652 |
454 | PROSTATE GLAND MORPHOGENESIS | 3 | 23 | 5.539e-05 | 0.0005652 |
455 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 3 | 23 | 5.539e-05 | 0.0005652 |
456 | POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 3 | 23 | 5.539e-05 | 0.0005652 |
457 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 7 | 303 | 5.61e-05 | 0.0005712 |
458 | POSITIVE REGULATION OF BINDING | 5 | 127 | 5.808e-05 | 0.0005901 |
459 | GERM CELL DEVELOPMENT | 6 | 209 | 5.992e-05 | 0.0006074 |
460 | POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 3 | 24 | 6.316e-05 | 0.000632 |
461 | POSITIVE REGULATION OF PROTEIN SECRETION | 6 | 211 | 6.316e-05 | 0.000632 |
462 | POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 3 | 24 | 6.316e-05 | 0.000632 |
463 | NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 3 | 24 | 6.316e-05 | 0.000632 |
464 | REGULATION OF REPRODUCTIVE PROCESS | 5 | 129 | 6.257e-05 | 0.000632 |
465 | LENS DEVELOPMENT IN CAMERA TYPE EYE | 4 | 66 | 6.294e-05 | 0.000632 |
466 | REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 6 | 213 | 6.655e-05 | 0.0006645 |
467 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 4 | 67 | 6.677e-05 | 0.0006653 |
468 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 11 | 829 | 6.705e-05 | 0.0006657 |
469 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 10 | 684 | 6.71e-05 | 0.0006657 |
470 | NEGATIVE REGULATION OF CELL CYCLE PROCESS | 6 | 214 | 6.83e-05 | 0.0006761 |
471 | REGULATION OF LYMPHOCYTE DIFFERENTIATION | 5 | 132 | 6.979e-05 | 0.0006895 |
472 | CELLULAR RESPONSE TO HORMONE STIMULUS | 9 | 552 | 7.032e-05 | 0.0006932 |
473 | CELL MOTILITY | 11 | 835 | 7.152e-05 | 0.0007021 |
474 | LOCALIZATION OF CELL | 11 | 835 | 7.152e-05 | 0.0007021 |
475 | RESPONSE TO DRUG | 8 | 431 | 7.51e-05 | 0.0007357 |
476 | MUSCLE STRUCTURE DEVELOPMENT | 8 | 432 | 7.632e-05 | 0.0007451 |
477 | REGULATION OF CELL CYCLE PROCESS | 9 | 558 | 7.638e-05 | 0.0007451 |
478 | CELL GROWTH | 5 | 135 | 7.764e-05 | 0.0007558 |
479 | NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 5 | 136 | 8.041e-05 | 0.0007811 |
480 | MESODERMAL CELL DIFFERENTIATION | 3 | 26 | 8.075e-05 | 0.0007828 |
481 | REGULATION OF PROTEIN STABILITY | 6 | 221 | 8.158e-05 | 0.0007891 |
482 | CIRCADIAN RHYTHM | 5 | 137 | 8.324e-05 | 0.0008019 |
483 | ACTIVATION OF MAPK ACTIVITY | 5 | 137 | 8.324e-05 | 0.0008019 |
484 | RESPONSE TO DSRNA | 4 | 72 | 8.854e-05 | 0.0008512 |
485 | ERYTHROCYTE HOMEOSTASIS | 4 | 73 | 9.345e-05 | 0.0008952 |
486 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 9 | 573 | 9.35e-05 | 0.0008952 |
487 | NEGATIVE REGULATION OF HORMONE SECRETION | 4 | 74 | 9.855e-05 | 0.0009416 |
488 | VENTRICULAR SEPTUM MORPHOGENESIS | 3 | 28 | 0.0001013 | 0.0009637 |
489 | POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 3 | 28 | 0.0001013 | 0.0009637 |
490 | BIOLOGICAL ADHESION | 12 | 1032 | 0.0001067 | 0.001013 |
491 | NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 3 | 29 | 0.0001127 | 0.001066 |
492 | REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 3 | 29 | 0.0001127 | 0.001066 |
493 | SEXUAL REPRODUCTION | 10 | 730 | 0.0001149 | 0.001081 |
494 | REGULATION OF DNA METABOLIC PROCESS | 7 | 340 | 0.0001153 | 0.001081 |
495 | NEGATIVE REGULATION OF DEPHOSPHORYLATION | 4 | 77 | 0.0001151 | 0.001081 |
496 | REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 4 | 77 | 0.0001151 | 0.001081 |
497 | POSITIVE REGULATION OF CELL GROWTH | 5 | 148 | 0.0001198 | 0.001122 |
498 | INTRACELLULAR SIGNAL TRANSDUCTION | 15 | 1572 | 0.0001223 | 0.001142 |
499 | SMOOTH MUSCLE CELL DIFFERENTIATION | 3 | 30 | 0.0001249 | 0.001165 |
500 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 5 | 152 | 0.0001358 | 0.001261 |
501 | REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 5 | 152 | 0.0001358 | 0.001261 |
502 | REGULATION OF MULTI ORGANISM PROCESS | 8 | 470 | 0.0001367 | 0.001267 |
503 | POSITIVE REGULATION OF CELL CELL ADHESION | 6 | 243 | 0.0001372 | 0.001269 |
504 | NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION | 4 | 82 | 0.0001469 | 0.001356 |
505 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 16 | 1791 | 0.0001497 | 0.001379 |
506 | POSITIVE REGULATION OF CELL CYCLE PROCESS | 6 | 247 | 0.00015 | 0.001379 |
507 | NUCLEAR TRANSPORT | 7 | 355 | 0.0001505 | 0.001381 |
508 | REGULATION OF ORGAN FORMATION | 3 | 32 | 0.0001519 | 0.001386 |
509 | PATTERNING OF BLOOD VESSELS | 3 | 32 | 0.0001519 | 0.001386 |
510 | BLOOD VESSEL REMODELING | 3 | 32 | 0.0001519 | 0.001386 |
511 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 5 | 156 | 0.0001534 | 0.001397 |
512 | PROTEOGLYCAN METABOLIC PROCESS | 4 | 83 | 0.000154 | 0.001399 |
513 | POSITIVE REGULATION OF MULTI ORGANISM PROCESS | 5 | 157 | 0.000158 | 0.001433 |
514 | EMBRYONIC AXIS SPECIFICATION | 3 | 33 | 0.0001667 | 0.001506 |
515 | REGULATION OF T CELL APOPTOTIC PROCESS | 3 | 33 | 0.0001667 | 0.001506 |
516 | POSITIVE REGULATION OF CELL CYCLE ARREST | 4 | 85 | 0.0001688 | 0.001522 |
517 | POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 4 | 86 | 0.0001766 | 0.00159 |
518 | CELL CYCLE PHASE TRANSITION | 6 | 255 | 0.0001783 | 0.001602 |
519 | RESPONSE TO FLUID SHEAR STRESS | 3 | 34 | 0.0001824 | 0.001632 |
520 | REGULATION OF PEPTIDE TRANSPORT | 6 | 256 | 0.0001821 | 0.001632 |
521 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 7 | 368 | 0.0001877 | 0.001676 |
522 | POSITIVE REGULATION OF CYTOKINE PRODUCTION | 7 | 370 | 0.000194 | 0.001729 |
523 | POST EMBRYONIC DEVELOPMENT | 4 | 89 | 0.0002016 | 0.001794 |
524 | NEGATIVE REGULATION OF LOCOMOTION | 6 | 263 | 0.0002107 | 0.001864 |
525 | REGULATION OF CELL MATRIX ADHESION | 4 | 90 | 0.0002105 | 0.001864 |
526 | ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 4 | 90 | 0.0002105 | 0.001864 |
527 | REGULATION OF ERYTHROCYTE DIFFERENTIATION | 3 | 36 | 0.0002167 | 0.001906 |
528 | CORTICAL CYTOSKELETON ORGANIZATION | 3 | 36 | 0.0002167 | 0.001906 |
529 | HEAD MORPHOGENESIS | 3 | 36 | 0.0002167 | 0.001906 |
530 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 8 | 505 | 0.0002231 | 0.001958 |
531 | NEGATIVE REGULATION OF CELL GROWTH | 5 | 170 | 0.0002289 | 0.002005 |
532 | HINDLIMB MORPHOGENESIS | 3 | 37 | 0.0002352 | 0.002054 |
533 | REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 3 | 37 | 0.0002352 | 0.002054 |
534 | REGULATION OF DNA BINDING | 4 | 93 | 0.0002388 | 0.002081 |
535 | REGULATION OF CELL DIVISION | 6 | 272 | 0.0002525 | 0.002196 |
536 | RESPONSE TO TESTOSTERONE | 3 | 38 | 0.0002548 | 0.002204 |
537 | CELLULAR RESPONSE TO DSRNA | 3 | 38 | 0.0002548 | 0.002204 |
538 | REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 3 | 38 | 0.0002548 | 0.002204 |
539 | HOMEOSTASIS OF NUMBER OF CELLS | 5 | 175 | 0.0002617 | 0.002259 |
540 | RESPONSE TO CORTICOSTEROID | 5 | 176 | 0.0002687 | 0.002315 |
541 | ANATOMICAL STRUCTURE MATURATION | 3 | 39 | 0.0002754 | 0.002369 |
542 | MUSCLE ORGAN DEVELOPMENT | 6 | 277 | 0.0002785 | 0.00239 |
543 | NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 4 | 98 | 0.0002918 | 0.002501 |
544 | NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 3 | 40 | 0.0002971 | 0.002541 |
545 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 14 | 1518 | 0.0003061 | 0.002611 |
546 | REGULATION OF LIPID METABOLIC PROCESS | 6 | 282 | 0.0003064 | 0.002611 |
547 | NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 3 | 41 | 0.0003198 | 0.002705 |
548 | POSITIVE REGULATION OF KIDNEY DEVELOPMENT | 3 | 41 | 0.0003198 | 0.002705 |
549 | PROSTATE GLAND DEVELOPMENT | 3 | 41 | 0.0003198 | 0.002705 |
550 | LUNG ALVEOLUS DEVELOPMENT | 3 | 41 | 0.0003198 | 0.002705 |
551 | NEURON PROJECTION MORPHOGENESIS | 7 | 402 | 0.0003211 | 0.002712 |
552 | REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 4 | 101 | 0.0003275 | 0.00276 |
553 | POSITIVE REGULATION OF DNA METABOLIC PROCESS | 5 | 185 | 0.0003381 | 0.002845 |
554 | POSTTRANSCRIPTIONAL GENE SILENCING | 3 | 42 | 0.0003436 | 0.00288 |
555 | EPITHELIAL CELL MORPHOGENESIS | 3 | 42 | 0.0003436 | 0.00288 |
556 | APOPTOTIC SIGNALING PATHWAY | 6 | 289 | 0.0003492 | 0.002923 |
557 | CARDIAC CHAMBER MORPHOGENESIS | 4 | 104 | 0.0003661 | 0.003058 |
558 | NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 3 | 43 | 0.0003685 | 0.003066 |
559 | LEUKOCYTE DIFFERENTIATION | 6 | 292 | 0.0003689 | 0.003066 |
560 | BETA CATENIN TCF COMPLEX ASSEMBLY | 3 | 43 | 0.0003685 | 0.003066 |
561 | RESPONSE TO NUTRIENT | 5 | 191 | 0.0003914 | 0.003246 |
562 | BODY MORPHOGENESIS | 3 | 44 | 0.0003945 | 0.003266 |
563 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 6 | 296 | 0.0003966 | 0.003278 |
564 | PLATELET DEGRANULATION | 4 | 107 | 0.0004079 | 0.003365 |
565 | NEGATIVE REGULATION OF PROTEIN SECRETION | 4 | 108 | 0.0004226 | 0.003462 |
566 | REGULATION OF EPIDERMAL CELL DIFFERENTIATION | 3 | 45 | 0.0004217 | 0.003462 |
567 | REGULATION OF CELL CYCLE ARREST | 4 | 108 | 0.0004226 | 0.003462 |
568 | REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 3 | 45 | 0.0004217 | 0.003462 |
569 | EAR DEVELOPMENT | 5 | 195 | 0.0004303 | 0.003519 |
570 | REGULATION OF CELL PROJECTION ORGANIZATION | 8 | 558 | 0.0004354 | 0.003554 |
571 | REGULATION OF PROTEOLYSIS | 9 | 711 | 0.0004643 | 0.003784 |
572 | RESPONSE TO ANTIBIOTIC | 3 | 47 | 0.0004797 | 0.003888 |
573 | RESPONSE TO CYTOKINE | 9 | 714 | 0.0004787 | 0.003888 |
574 | POSITIVE REGULATION OF DEPHOSPHORYLATION | 3 | 47 | 0.0004797 | 0.003888 |
575 | NEGATIVE REGULATION OF SECRETION | 5 | 200 | 0.000483 | 0.003908 |
576 | CELL ACTIVATION | 8 | 568 | 0.0004896 | 0.003955 |
577 | REGULATION OF MYOBLAST DIFFERENTIATION | 3 | 48 | 0.0005105 | 0.004109 |
578 | REGULATION OF ENDOCRINE PROCESS | 3 | 48 | 0.0005105 | 0.004109 |
579 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 6 | 312 | 0.0005238 | 0.004209 |
580 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 9 | 724 | 0.0005292 | 0.004246 |
581 | NEGATIVE REGULATION OF PEPTIDE SECRETION | 3 | 49 | 0.0005425 | 0.004337 |
582 | REGULATION OF STEROID BIOSYNTHETIC PROCESS | 3 | 49 | 0.0005425 | 0.004337 |
583 | ENDOCARDIUM DEVELOPMENT | 2 | 11 | 0.0005613 | 0.004457 |
584 | REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 2 | 11 | 0.0005613 | 0.004457 |
585 | LYMPHANGIOGENESIS | 2 | 11 | 0.0005613 | 0.004457 |
586 | REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 2 | 11 | 0.0005613 | 0.004457 |
587 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 5 | 207 | 0.0005647 | 0.004476 |
588 | RESPONSE TO PROGESTERONE | 3 | 50 | 0.0005758 | 0.004541 |
589 | ENDODERM FORMATION | 3 | 50 | 0.0005758 | 0.004541 |
590 | POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 3 | 50 | 0.0005758 | 0.004541 |
591 | NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 5 | 209 | 0.0005899 | 0.004636 |
592 | REGULATION OF PEPTIDE SECRETION | 5 | 209 | 0.0005899 | 0.004636 |
593 | SINGLE ORGANISM CELLULAR LOCALIZATION | 10 | 898 | 0.0006015 | 0.00472 |
594 | RESPONSE TO MECHANICAL STIMULUS | 5 | 210 | 0.0006027 | 0.004721 |
595 | REGULATION OF CELL CYCLE PHASE TRANSITION | 6 | 321 | 0.0006081 | 0.004755 |
596 | ARTERY MORPHOGENESIS | 3 | 51 | 0.0006104 | 0.004765 |
597 | POSITIVE REGULATION OF CHEMOTAXIS | 4 | 120 | 0.0006292 | 0.004904 |
598 | POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 2 | 12 | 0.0006722 | 0.005153 |
599 | NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 2 | 12 | 0.0006722 | 0.005153 |
600 | REGULATION OF VITAMIN METABOLIC PROCESS | 2 | 12 | 0.0006722 | 0.005153 |
601 | REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 2 | 12 | 0.0006722 | 0.005153 |
602 | HEART FORMATION | 2 | 12 | 0.0006722 | 0.005153 |
603 | REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS | 2 | 12 | 0.0006722 | 0.005153 |
604 | MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 2 | 12 | 0.0006722 | 0.005153 |
605 | GROWTH PLATE CARTILAGE DEVELOPMENT | 2 | 12 | 0.0006722 | 0.005153 |
606 | NEGATIVE REGULATION OF HEART GROWTH | 2 | 12 | 0.0006722 | 0.005153 |
607 | POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 2 | 12 | 0.0006722 | 0.005153 |
608 | NEGATIVE REGULATION OF TRANSPORT | 7 | 458 | 0.0006985 | 0.005346 |
609 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 5 | 218 | 0.0007136 | 0.005452 |
610 | NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 3 | 54 | 0.000722 | 0.005489 |
611 | REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 3 | 54 | 0.000722 | 0.005489 |
612 | CARDIAC MUSCLE TISSUE MORPHOGENESIS | 3 | 54 | 0.000722 | 0.005489 |
613 | NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 2 | 13 | 0.0007927 | 0.00594 |
614 | POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS | 2 | 13 | 0.0007927 | 0.00594 |
615 | MITOTIC CELL CYCLE | 9 | 766 | 0.000792 | 0.00594 |
616 | BEHAVIORAL RESPONSE TO PAIN | 2 | 13 | 0.0007927 | 0.00594 |
617 | LEUKOCYTE TETHERING OR ROLLING | 2 | 13 | 0.0007927 | 0.00594 |
618 | LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 2 | 13 | 0.0007927 | 0.00594 |
619 | LYMPH VESSEL MORPHOGENESIS | 2 | 13 | 0.0007927 | 0.00594 |
620 | TELENCEPHALON REGIONALIZATION | 2 | 13 | 0.0007927 | 0.00594 |
621 | MESODERMAL CELL FATE COMMITMENT | 2 | 13 | 0.0007927 | 0.00594 |
622 | NEGATIVE REGULATION OF HEMOPOIESIS | 4 | 128 | 0.0008014 | 0.005995 |
623 | REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 3 | 57 | 0.0008458 | 0.006317 |
624 | POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION | 4 | 131 | 0.0008738 | 0.006484 |
625 | NEGATIVE REGULATION OF BINDING | 4 | 131 | 0.0008738 | 0.006484 |
626 | RETINA DEVELOPMENT IN CAMERA TYPE EYE | 4 | 131 | 0.0008738 | 0.006484 |
627 | TELENCEPHALON DEVELOPMENT | 5 | 228 | 0.0008728 | 0.006484 |
628 | PROTEOGLYCAN BIOSYNTHETIC PROCESS | 3 | 58 | 0.0008898 | 0.006583 |
629 | POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS | 3 | 58 | 0.0008898 | 0.006583 |
630 | MAINTENANCE OF CELL NUMBER | 4 | 132 | 0.0008989 | 0.006639 |
631 | POSITIVE REGULATION OF P38MAPK CASCADE | 2 | 14 | 0.0009229 | 0.006763 |
632 | METANEPHRIC MESENCHYME DEVELOPMENT | 2 | 14 | 0.0009229 | 0.006763 |
633 | CRANIOFACIAL SUTURE MORPHOGENESIS | 2 | 14 | 0.0009229 | 0.006763 |
634 | ADENOHYPOPHYSIS DEVELOPMENT | 2 | 14 | 0.0009229 | 0.006763 |
635 | BONE MATURATION | 2 | 14 | 0.0009229 | 0.006763 |
636 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 5 | 232 | 0.0009434 | 0.006902 |
637 | RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 233 | 0.0009617 | 0.007025 |
638 | REGULATION OF CELL ACTIVATION | 7 | 484 | 0.0009648 | 0.007037 |
639 | PROTEIN COMPLEX BIOGENESIS | 11 | 1132 | 0.0009732 | 0.007075 |
640 | PROTEIN COMPLEX ASSEMBLY | 11 | 1132 | 0.0009732 | 0.007075 |
641 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 4 | 135 | 0.0009773 | 0.007095 |
642 | NEGATIVE REGULATION OF CELL DIVISION | 3 | 60 | 0.0009823 | 0.007108 |
643 | REGULATION OF MONOOXYGENASE ACTIVITY | 3 | 60 | 0.0009823 | 0.007108 |
644 | SECRETION BY CELL | 7 | 486 | 0.0009882 | 0.00714 |
645 | REGULATION OF HYDROLASE ACTIVITY | 12 | 1327 | 0.001048 | 0.007559 |
646 | N TERMINAL PROTEIN AMINO ACID ACETYLATION | 2 | 15 | 0.001063 | 0.007572 |
647 | ENDOCARDIAL CUSHION FORMATION | 2 | 15 | 0.001063 | 0.007572 |
648 | REGULATION OF MESODERM DEVELOPMENT | 2 | 15 | 0.001063 | 0.007572 |
649 | REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 2 | 15 | 0.001063 | 0.007572 |
650 | STRIATED MUSCLE CELL PROLIFERATION | 2 | 15 | 0.001063 | 0.007572 |
651 | CHRONIC INFLAMMATORY RESPONSE | 2 | 15 | 0.001063 | 0.007572 |
652 | POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 2 | 15 | 0.001063 | 0.007572 |
653 | POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 2 | 15 | 0.001063 | 0.007572 |
654 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 9 | 799 | 0.001066 | 0.007586 |
655 | SENSORY ORGAN MORPHOGENESIS | 5 | 239 | 0.001077 | 0.007652 |
656 | MITOTIC CELL CYCLE CHECKPOINT | 4 | 139 | 0.001089 | 0.007726 |
657 | PROTEIN COMPLEX SUBUNIT ORGANIZATION | 13 | 1527 | 0.001102 | 0.007802 |
658 | RESPONSE TO TOXIC SUBSTANCE | 5 | 241 | 0.001118 | 0.007904 |
659 | REGULATION OF CYTOSKELETON ORGANIZATION | 7 | 502 | 0.001192 | 0.008417 |
660 | MODULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST | 2 | 16 | 0.001212 | 0.008493 |
661 | REGULATION OF MONONUCLEAR CELL MIGRATION | 2 | 16 | 0.001212 | 0.008493 |
662 | ORGAN INDUCTION | 2 | 16 | 0.001212 | 0.008493 |
663 | POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 2 | 16 | 0.001212 | 0.008493 |
664 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 2 | 16 | 0.001212 | 0.008493 |
665 | SOMATIC STEM CELL POPULATION MAINTENANCE | 3 | 66 | 0.001295 | 0.009051 |
666 | CELLULAR RESPONSE TO UV | 3 | 66 | 0.001295 | 0.009051 |
667 | NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 4 | 146 | 0.001306 | 0.009113 |
668 | NEGATIVE REGULATION OF KIDNEY DEVELOPMENT | 2 | 17 | 0.001371 | 0.009505 |
669 | EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 2 | 17 | 0.001371 | 0.009505 |
670 | POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 2 | 17 | 0.001371 | 0.009505 |
671 | POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 2 | 17 | 0.001371 | 0.009505 |
672 | PEPTIDYL SERINE MODIFICATION | 4 | 148 | 0.001373 | 0.00951 |
673 | MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 3 | 68 | 0.001412 | 0.009764 |
674 | LEUKOCYTE CELL CELL ADHESION | 5 | 255 | 0.001435 | 0.009907 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 18 | 50 | 2.061e-33 | 1.914e-30 |
2 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 19 | 172 | 1.802e-24 | 8.37e-22 |
3 | SMAD BINDING | 15 | 72 | 8.407e-24 | 2.603e-21 |
4 | CYTOKINE RECEPTOR BINDING | 20 | 271 | 3.531e-22 | 8.201e-20 |
5 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 10 | 17 | 1.215e-21 | 2.258e-19 |
6 | I SMAD BINDING | 7 | 11 | 8.964e-16 | 1.388e-13 |
7 | GROWTH FACTOR ACTIVITY | 13 | 160 | 3.846e-15 | 5.104e-13 |
8 | RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY | 11 | 92 | 7.69e-15 | 8.931e-13 |
9 | CYTOKINE ACTIVITY | 14 | 219 | 8.744e-15 | 9.025e-13 |
10 | RECEPTOR SERINE THREONINE KINASE BINDING | 7 | 15 | 1.73e-14 | 1.607e-12 |
11 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 10 | 81 | 9.996e-14 | 8.442e-12 |
12 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 16 | 445 | 6.591e-13 | 5.102e-11 |
13 | ACTIVIN BINDING | 6 | 12 | 8.463e-13 | 6.048e-11 |
14 | TRANSFORMING GROWTH FACTOR BETA BINDING | 6 | 16 | 7.261e-12 | 4.497e-10 |
15 | GROWTH FACTOR BINDING | 10 | 123 | 7.185e-12 | 4.497e-10 |
16 | RECEPTOR BINDING | 24 | 1476 | 1.178e-11 | 6.839e-10 |
17 | CYTOKINE BINDING | 9 | 92 | 1.599e-11 | 8.737e-10 |
18 | PROTEIN DIMERIZATION ACTIVITY | 21 | 1149 | 3.948e-11 | 2.038e-09 |
19 | TRANSCRIPTION FACTOR BINDING | 15 | 524 | 9.586e-11 | 4.687e-09 |
20 | IDENTICAL PROTEIN BINDING | 21 | 1209 | 1.016e-10 | 4.72e-09 |
21 | PROTEIN KINASE ACTIVITY | 16 | 640 | 1.516e-10 | 6.707e-09 |
22 | KINASE ACTIVITY | 16 | 842 | 7.911e-09 | 3.34e-07 |
23 | R SMAD BINDING | 5 | 23 | 9.968e-09 | 4.026e-07 |
24 | SIGNAL TRANSDUCER ACTIVITY | 22 | 1731 | 1.153e-08 | 4.462e-07 |
25 | GLYCOSAMINOGLYCAN BINDING | 9 | 205 | 2.039e-08 | 7.576e-07 |
26 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 18 | 1199 | 2.97e-08 | 1.061e-06 |
27 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 7 | 104 | 4.556e-08 | 1.567e-06 |
28 | CO SMAD BINDING | 4 | 12 | 4.931e-08 | 1.636e-06 |
29 | MACROMOLECULAR COMPLEX BINDING | 19 | 1399 | 5.507e-08 | 1.764e-06 |
30 | PROTEIN HOMODIMERIZATION ACTIVITY | 14 | 722 | 6.234e-08 | 1.931e-06 |
31 | COLLAGEN BINDING | 6 | 65 | 6.615e-08 | 1.982e-06 |
32 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 16 | 992 | 7.781e-08 | 2.259e-06 |
33 | PROTEIN COMPLEX BINDING | 15 | 935 | 2.303e-07 | 6.482e-06 |
34 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 10 | 371 | 3.089e-07 | 8.441e-06 |
35 | HEPARIN BINDING | 7 | 157 | 7.634e-07 | 2.026e-05 |
36 | SULFUR COMPOUND BINDING | 8 | 234 | 8.856e-07 | 2.285e-05 |
37 | ACTIVATING TRANSCRIPTION FACTOR BINDING | 5 | 57 | 1.139e-06 | 2.861e-05 |
38 | REGULATORY REGION NUCLEIC ACID BINDING | 13 | 818 | 1.866e-06 | 4.561e-05 |
39 | BHLH TRANSCRIPTION FACTOR BINDING | 4 | 28 | 1.962e-06 | 4.673e-05 |
40 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 11 | 629 | 5.219e-06 | 0.0001212 |
41 | RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING | 4 | 36 | 5.534e-06 | 0.0001254 |
42 | DOUBLE STRANDED DNA BINDING | 11 | 764 | 3.201e-05 | 0.000708 |
43 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 7 | 328 | 9.219e-05 | 0.001992 |
44 | PROTEIN HETERODIMERIZATION ACTIVITY | 8 | 468 | 0.0001328 | 0.002803 |
45 | ADENYL NUCLEOTIDE BINDING | 14 | 1514 | 0.000298 | 0.006151 |
46 | GLYCOPROTEIN BINDING | 4 | 101 | 0.0003275 | 0.006473 |
47 | CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 4 | 101 | 0.0003275 | 0.006473 |
48 | ENZYME BINDING | 15 | 1737 | 0.0003647 | 0.007059 |
49 | SEQUENCE SPECIFIC DNA BINDING | 11 | 1037 | 0.0004704 | 0.008919 |
50 | CHROMATIN BINDING | 7 | 435 | 0.0005151 | 0.00957 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | TRANSCRIPTION FACTOR COMPLEX | 15 | 298 | 2.959e-14 | 1.728e-11 |
2 | EXTRACELLULAR SPACE | 20 | 1376 | 7.012e-09 | 2.048e-06 |
3 | RECEPTOR COMPLEX | 10 | 327 | 9.607e-08 | 1.87e-05 |
4 | EXTRACELLULAR MATRIX | 10 | 426 | 1.088e-06 | 0.0001589 |
5 | PLASMA MEMBRANE RECEPTOR COMPLEX | 7 | 175 | 1.581e-06 | 0.0001847 |
6 | PLATELET ALPHA GRANULE | 5 | 75 | 4.49e-06 | 0.0004213 |
7 | CELL SURFACE | 12 | 757 | 5.05e-06 | 0.0004213 |
8 | PLATELET ALPHA GRANULE LUMEN | 4 | 55 | 3.059e-05 | 0.002233 |
9 | MEMBRANE MICRODOMAIN | 7 | 288 | 4.07e-05 | 0.002377 |
10 | PLASMA MEMBRANE PROTEIN COMPLEX | 9 | 510 | 3.818e-05 | 0.002377 |
11 | EXTERNAL SIDE OF PLASMA MEMBRANE | 6 | 238 | 0.0001225 | 0.006504 |
12 | SECRETORY GRANULE LUMEN | 4 | 85 | 0.0001688 | 0.007935 |
13 | PLASMA MEMBRANE RAFT | 4 | 86 | 0.0001766 | 0.007935 |
14 | PROTEIN KINASE COMPLEX | 4 | 90 | 0.0002105 | 0.008781 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04350_TGF.beta_signaling_pathway | 64 | 85 | 2.147e-165 | 3.865e-163 | |
2 | hsa04390_Hippo_signaling_pathway | 23 | 154 | 7.671e-33 | 6.904e-31 | |
3 | hsa04110_Cell_cycle | 13 | 128 | 2.008e-16 | 1.205e-14 | |
4 | hsa04144_Endocytosis | 11 | 203 | 4.979e-11 | 2.013e-09 | |
5 | hsa04310_Wnt_signaling_pathway | 10 | 151 | 5.591e-11 | 2.013e-09 | |
6 | hsa04520_Adherens_junction | 8 | 73 | 9.073e-11 | 2.722e-09 | |
7 | hsa04151_PI3K_AKT_signaling_pathway | 11 | 351 | 1.598e-08 | 4.108e-07 | |
8 | hsa04340_Hedgehog_signaling_pathway | 5 | 56 | 1.042e-06 | 2.344e-05 | |
9 | hsa04380_Osteoclast_differentiation | 6 | 128 | 3.704e-06 | 6.907e-05 | |
10 | hsa04510_Focal_adhesion | 7 | 200 | 3.837e-06 | 6.907e-05 | |
11 | hsa04010_MAPK_signaling_pathway | 7 | 268 | 2.573e-05 | 0.000421 | |
12 | hsa04512_ECM.receptor_interaction | 4 | 85 | 0.0001688 | 0.002533 | |
13 | hsa04012_ErbB_signaling_pathway | 4 | 87 | 0.0001847 | 0.002558 | |
14 | hsa04150_mTOR_signaling_pathway | 3 | 52 | 0.0006462 | 0.008309 | |
15 | hsa04720_Long.term_potentiation | 3 | 70 | 0.001535 | 0.01666 | |
16 | hsa04730_Long.term_depression | 3 | 70 | 0.001535 | 0.01666 | |
17 | hsa04630_Jak.STAT_signaling_pathway | 4 | 155 | 0.001628 | 0.01666 | |
18 | hsa04145_Phagosome | 4 | 156 | 0.001666 | 0.01666 | |
19 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 3 | 95 | 0.003665 | 0.03472 | |
20 | hsa04916_Melanogenesis | 3 | 101 | 0.004352 | 0.03917 | |
21 | hsa04660_T_cell_receptor_signaling_pathway | 3 | 108 | 0.005246 | 0.04497 | |
22 | hsa04114_Oocyte_meiosis | 3 | 114 | 0.006095 | 0.04987 | |
23 | hsa04270_Vascular_smooth_muscle_contraction | 3 | 116 | 0.006395 | 0.05005 | |
24 | hsa04360_Axon_guidance | 3 | 130 | 0.008741 | 0.06556 | |
25 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 3 | 136 | 0.009882 | 0.06854 | |
26 | hsa04330_Notch_signaling_pathway | 2 | 47 | 0.01023 | 0.06854 | |
27 | hsa04910_Insulin_signaling_pathway | 3 | 138 | 0.01028 | 0.06854 | |
28 | hsa04621_NOD.like_receptor_signaling_pathway | 2 | 59 | 0.0158 | 0.1016 | |
29 | hsa04062_Chemokine_signaling_pathway | 3 | 189 | 0.02365 | 0.1468 | |
30 | hsa04612_Antigen_processing_and_presentation | 2 | 78 | 0.02666 | 0.1585 | |
31 | hsa04664_Fc_epsilon_RI_signaling_pathway | 2 | 79 | 0.02729 | 0.1585 | |
32 | hsa03015_mRNA_surveillance_pathway | 2 | 83 | 0.0299 | 0.1682 | |
33 | hsa04810_Regulation_of_actin_cytoskeleton | 3 | 214 | 0.03249 | 0.1772 | |
34 | hsa04620_Toll.like_receptor_signaling_pathway | 2 | 102 | 0.04352 | 0.2304 | |
35 | hsa04670_Leukocyte_transendothelial_migration | 2 | 117 | 0.0556 | 0.2859 | |
36 | hsa04530_Tight_junction | 2 | 133 | 0.06961 | 0.348 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | MAGI2-AS3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-93-5p | 13 | THBS2 | Sponge network | -4.563 | 0 | -2.628 | 0.00636 | 0.694 |
2 | MAGI2-AS3 |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-500a-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-92a-3p | 18 | THBS1 | Sponge network | -4.563 | 0 | -3.751 | 0.0001 | 0.664 |
3 | RP11-166D19.1 |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-92a-3p | 16 | THBS1 | Sponge network | -4.209 | 2.0E-5 | -3.751 | 0.0001 | 0.639 |
4 | MIR143HG |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p | 12 | THBS2 | Sponge network | -6.51 | 0 | -2.628 | 0.00636 | 0.606 |
5 | MIR143HG |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-500a-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-92a-3p | 18 | THBS1 | Sponge network | -6.51 | 0 | -3.751 | 0.0001 | 0.603 |
6 | DNM3OS |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p | 13 | THBS2 | Sponge network | -3.933 | 0.00059 | -2.628 | 0.00636 | 0.597 |
7 | MEG3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-3614-5p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p | 11 | THBS2 | Sponge network | -3.613 | 0.00075 | -2.628 | 0.00636 | 0.586 |
8 | RP11-166D19.1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-96-5p | 13 | THBS2 | Sponge network | -4.209 | 2.0E-5 | -2.628 | 0.00636 | 0.584 |
9 | DNM3OS |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p | 15 | THBS1 | Sponge network | -3.933 | 0.00059 | -3.751 | 0.0001 | 0.584 |
10 | NR2F2-AS1 |
hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-590-3p;hsa-miR-9-3p;hsa-miR-92a-3p;hsa-miR-93-5p | 12 | TGFBR2 | Sponge network | -3.785 | 0.00281 | -2.733 | 2.0E-5 | 0.556 |
11 | MEG3 |
hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-616-5p | 14 | THBS1 | Sponge network | -3.613 | 0.00075 | -3.751 | 0.0001 | 0.544 |
12 | RP11-344E13.3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-29b-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p | 12 | THBS2 | Sponge network | -4.307 | 3.0E-5 | -2.628 | 0.00636 | 0.485 |
13 | MAGI2-AS3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-502-5p;hsa-miR-590-3p;hsa-miR-9-3p;hsa-miR-92a-3p;hsa-miR-93-5p | 17 | TGFBR2 | Sponge network | -4.563 | 0 | -2.733 | 2.0E-5 | 0.479 |
14 | TPTEP1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p | 10 | THBS2 | Sponge network | -4.398 | 5.0E-5 | -2.628 | 0.00636 | 0.465 |
15 | LINC00284 |
hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p | 10 | TGFBR2 | Sponge network | -5.478 | 0.02716 | -2.733 | 2.0E-5 | 0.434 |
16 | RP11-166D19.1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-9-5p;hsa-miR-92a-3p | 16 | TGFBR2 | Sponge network | -4.209 | 2.0E-5 | -2.733 | 2.0E-5 | 0.422 |
17 | CTD-2334D19.1 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-93-5p | 10 | TGFBR2 | Sponge network | -4.489 | 0.03789 | -2.733 | 2.0E-5 | 0.419 |
18 | EMX2OS |
hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-5p | 13 | TGFBR2 | Sponge network | -6.205 | 0.00015 | -2.733 | 2.0E-5 | 0.417 |
19 | HAND2-AS1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-93-5p | 11 | THBS2 | Sponge network | -7.871 | 0 | -2.628 | 0.00636 | 0.398 |
20 | HAND2-AS1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-5p | 14 | TGFBR2 | Sponge network | -7.871 | 0 | -2.733 | 2.0E-5 | 0.394 |
21 | ACTA2-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-590-3p;hsa-miR-93-3p | 12 | BMPR2 | Sponge network | -6.142 | 0.00223 | -1.126 | 0.00109 | 0.39 |
22 | RP11-166D19.1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-96-5p | 10 | SMAD7 | Sponge network | -4.209 | 2.0E-5 | -0.959 | 0.0367 | 0.387 |
23 | DNM3OS |
hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-3p;hsa-miR-93-5p | 12 | BMPR2 | Sponge network | -3.933 | 0.00059 | -1.126 | 0.00109 | 0.382 |
24 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p | 17 | BMPR2 | Sponge network | -4.563 | 0 | -1.126 | 0.00109 | 0.376 |
25 | TPTEP1 |
hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p | 10 | THBS1 | Sponge network | -4.398 | 5.0E-5 | -3.751 | 0.0001 | 0.373 |
26 | HAND2-AS1 |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-92a-3p | 15 | THBS1 | Sponge network | -7.871 | 0 | -3.751 | 0.0001 | 0.372 |
27 | LINC00473 | hsa-miR-106a-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-23b-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-9-3p;hsa-miR-9-5p;hsa-miR-92a-3p | 10 | TGFBR2 | Sponge network | -6.247 | 0.02928 | -2.733 | 2.0E-5 | 0.371 |
28 | ACTA2-AS1 |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p | 13 | THBS1 | Sponge network | -6.142 | 0.00223 | -3.751 | 0.0001 | 0.37 |
29 | RP11-389C8.2 |
hsa-let-7b-5p;hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-33a-3p | 12 | THBS1 | Sponge network | -3.089 | 2.0E-5 | -3.751 | 0.0001 | 0.369 |
30 | DNM3OS |
hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-27a-3p;hsa-miR-3065-5p;hsa-miR-320c;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-625-3p;hsa-miR-629-3p | 10 | SMAD9 | Sponge network | -3.933 | 0.00059 | -2.738 | 0.0193 | 0.368 |
31 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-3065-5p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-625-3p;hsa-miR-629-3p | 11 | SMAD9 | Sponge network | -4.563 | 0 | -2.738 | 0.0193 | 0.367 |
32 | RP11-567M16.1 |
hsa-miR-106b-5p;hsa-miR-146b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-5p;hsa-miR-93-5p | 10 | THBS2 | Sponge network | -2.638 | 0.21408 | -2.628 | 0.00636 | 0.363 |
33 | MIR143HG |
hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-200b-3p;hsa-miR-224-3p;hsa-miR-3065-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-3607-3p | 10 | INHBA | Sponge network | -6.51 | 0 | 0.597 | 0.64331 | 0.362 |
34 | ADAMTS9-AS1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p | 14 | THBS2 | Sponge network | -8.573 | 0.00012 | -2.628 | 0.00636 | 0.355 |
35 | MIR143HG |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-5p | 14 | TGFBR2 | Sponge network | -6.51 | 0 | -2.733 | 2.0E-5 | 0.353 |
36 | WT1-AS |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-96-5p | 12 | THBS2 | Sponge network | -6.875 | 2.0E-5 | -2.628 | 0.00636 | 0.351 |
37 | RP11-344E13.3 |
hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-3p;hsa-miR-93-5p | 13 | BMPR2 | Sponge network | -4.307 | 3.0E-5 | -1.126 | 0.00109 | 0.34 |
38 | NR2F1-AS1 | hsa-let-7f-1-3p;hsa-miR-146b-3p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p | 11 | BMPR2 | Sponge network | -2.961 | 0.00154 | -1.126 | 0.00109 | 0.336 |
39 | DNM3OS |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p | 15 | TGFBR2 | Sponge network | -3.933 | 0.00059 | -2.733 | 2.0E-5 | 0.336 |
40 | RP11-1036E20.9 | hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-502-5p;hsa-miR-92a-3p;hsa-miR-93-5p | 10 | TGFBR2 | Sponge network | -0.331 | 0.90522 | -2.733 | 2.0E-5 | 0.335 |
41 | SNHG14 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-27a-3p;hsa-miR-3065-5p;hsa-miR-320c;hsa-miR-330-3p;hsa-miR-452-3p;hsa-miR-629-3p | 10 | SMAD9 | Sponge network | -3.108 | 0.00332 | -2.738 | 0.0193 | 0.334 |
42 | MIR143HG |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-34a-5p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-93-5p | 11 | SMAD7 | Sponge network | -6.51 | 0 | -0.959 | 0.0367 | 0.333 |
43 | MAGI2-AS3 |
hsa-miR-107;hsa-miR-142-3p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-197-3p;hsa-miR-19b-3p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30e-5p;hsa-miR-362-3p;hsa-miR-454-3p;hsa-miR-590-3p | 13 | ACVR1 | Sponge network | -4.563 | 0 | -0.765 | 0.04389 | 0.332 |
44 | RP11-819C21.1 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-590-3p;hsa-miR-93-5p | 11 | BMPR2 | Sponge network | -1.571 | 0.00379 | -1.126 | 0.00109 | 0.331 |
45 | SOCS2-AS1 | hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-616-5p | 10 | THBS1 | Sponge network | -4.167 | 1.0E-5 | -3.751 | 0.0001 | 0.33 |
46 | MEG3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-5p;hsa-miR-93-5p | 14 | TGFBR2 | Sponge network | -3.613 | 0.00075 | -2.733 | 2.0E-5 | 0.325 |
47 | RP11-344E13.3 |
hsa-miR-107;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-338-3p;hsa-miR-454-3p;hsa-miR-590-3p | 10 | ACVR1 | Sponge network | -4.307 | 3.0E-5 | -0.765 | 0.04389 | 0.325 |
48 | WDR86-AS1 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-9-3p | 10 | TGFBR2 | Sponge network | -2.587 | 0.08454 | -2.733 | 2.0E-5 | 0.325 |
49 | AC003090.1 |
hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p | 10 | THBS2 | Sponge network | -7.817 | 0.00161 | -2.628 | 0.00636 | 0.321 |
50 | RP11-166D19.1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p | 15 | BMPR2 | Sponge network | -4.209 | 2.0E-5 | -1.126 | 0.00109 | 0.321 |
51 | HAND2-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p | 16 | BMPR2 | Sponge network | -7.871 | 0 | -1.126 | 0.00109 | 0.317 |
52 | TRHDE-AS1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p | 13 | THBS2 | Sponge network | -6.205 | 0.01165 | -2.628 | 0.00636 | 0.315 |
53 | ACTA2-AS1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-29b-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-96-5p | 12 | THBS2 | Sponge network | -6.142 | 0.00223 | -2.628 | 0.00636 | 0.313 |
54 | ACTA2-AS1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-590-3p | 12 | TGFBR2 | Sponge network | -6.142 | 0.00223 | -2.733 | 2.0E-5 | 0.31 |
55 | IGF2-AS | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-146b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-93-3p;hsa-miR-93-5p | 10 | BMPR2 | Sponge network | -7.051 | 0.01788 | -1.126 | 0.00109 | 0.31 |
56 | RP11-130L8.1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p | 11 | TGFBR2 | Sponge network | -4.329 | 1.0E-5 | -2.733 | 2.0E-5 | 0.307 |
57 | MAGI2-AS3 |
hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-148b-3p;hsa-miR-200a-3p;hsa-miR-2277-5p;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-500a-5p;hsa-miR-500b-5p;hsa-miR-616-5p;hsa-miR-9-3p | 13 | TGFB2 | Sponge network | -4.563 | 0 | -1.437 | 0.20815 | 0.306 |
58 | RP11-116O18.1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p | 12 | TGFBR2 | Sponge network | -5.007 | 0.06008 | -2.733 | 2.0E-5 | 0.306 |
59 | MAGI2-AS3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-93-5p | 10 | SMAD7 | Sponge network | -4.563 | 0 | -0.959 | 0.0367 | 0.304 |
60 | RP11-116O18.1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p | 13 | BMPR2 | Sponge network | -5.007 | 0.06008 | -1.126 | 0.00109 | 0.302 |
61 | LINC00284 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-330-3p;hsa-miR-3682-3p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-944 | 12 | SMAD9 | Sponge network | -5.478 | 0.02716 | -2.738 | 0.0193 | 0.299 |
62 | PWAR6 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-320c;hsa-miR-330-3p;hsa-miR-629-3p;hsa-miR-944 | 10 | SMAD9 | Sponge network | -3.15 | 0.0082 | -2.738 | 0.0193 | 0.298 |
63 | LINC00865 | hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-500a-5p;hsa-miR-616-5p | 12 | THBS1 | Sponge network | -1.585 | 0.19508 | -3.751 | 0.0001 | 0.29 |
64 | RP11-567M16.1 |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-616-5p | 10 | THBS1 | Sponge network | -2.638 | 0.21408 | -3.751 | 0.0001 | 0.29 |
65 | EMX2OS |
hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-93-5p | 10 | THBS2 | Sponge network | -6.205 | 0.00015 | -2.628 | 0.00636 | 0.29 |
66 | MEG3 |
hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-590-5p;hsa-miR-93-3p;hsa-miR-93-5p | 12 | BMPR2 | Sponge network | -3.613 | 0.00075 | -1.126 | 0.00109 | 0.29 |
67 | HAND2-AS1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-34a-5p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-93-5p | 11 | SMAD7 | Sponge network | -7.871 | 0 | -0.959 | 0.0367 | 0.289 |
68 | ZNF667-AS1 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-590-5p;hsa-miR-93-5p | 11 | BMPR2 | Sponge network | -4.019 | 0.00137 | -1.126 | 0.00109 | 0.288 |
69 | RP11-822E23.8 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-93-3p;hsa-miR-93-5p | 12 | BMPR2 | Sponge network | -8.351 | 0.00374 | -1.126 | 0.00109 | 0.287 |
70 | RP11-284N8.3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-590-5p;hsa-miR-93-5p | 10 | TGFBR2 | Sponge network | -0.845 | 0.52848 | -2.733 | 2.0E-5 | 0.286 |
71 | RP4-798P15.3 | hsa-let-7a-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-30b-5p;hsa-miR-30e-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-3p | 10 | BMPR2 | Sponge network | -0.893 | 0.37877 | -1.126 | 0.00109 | 0.285 |
72 | MIR497HG |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-500a-5p | 11 | THBS1 | Sponge network | -6.146 | 0.00024 | -3.751 | 0.0001 | 0.282 |
73 | MIR143HG |
hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p | 17 | BMPR2 | Sponge network | -6.51 | 0 | -1.126 | 0.00109 | 0.282 |
74 | MIR143HG |
hsa-miR-107;hsa-miR-142-3p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-197-3p;hsa-miR-19b-3p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-590-3p | 12 | ACVR1 | Sponge network | -6.51 | 0 | -0.765 | 0.04389 | 0.281 |
75 | RP11-344E13.3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-34a-5p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-93-5p | 10 | SMAD7 | Sponge network | -4.307 | 3.0E-5 | -0.959 | 0.0367 | 0.279 |
76 | EMX2OS |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-92a-3p | 13 | THBS1 | Sponge network | -6.205 | 0.00015 | -3.751 | 0.0001 | 0.273 |
77 | ADAMTS9-AS1 |
hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-3682-3p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-625-3p;hsa-miR-629-3p | 10 | SMAD9 | Sponge network | -8.573 | 0.00012 | -2.738 | 0.0193 | 0.27 |
78 | EMX2OS |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-330-3p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-944 | 11 | SMAD9 | Sponge network | -6.205 | 0.00015 | -2.738 | 0.0193 | 0.268 |
79 | TRHDE-AS1 |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-92a-3p | 11 | THBS1 | Sponge network | -6.205 | 0.01165 | -3.751 | 0.0001 | 0.266 |
80 | NR2F2-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p | 13 | BMPR2 | Sponge network | -3.785 | 0.00281 | -1.126 | 0.00109 | 0.265 |
81 | RP11-166D19.1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-27a-3p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-625-3p;hsa-miR-629-3p;hsa-miR-944 | 10 | SMAD9 | Sponge network | -4.209 | 2.0E-5 | -2.738 | 0.0193 | 0.265 |
82 | ADAMTS9-AS1 |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-92a-3p | 15 | THBS1 | Sponge network | -8.573 | 0.00012 | -3.751 | 0.0001 | 0.263 |
83 | TPTEP1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-27a-3p;hsa-miR-3682-3p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-625-3p;hsa-miR-629-3p | 10 | SMAD9 | Sponge network | -4.398 | 5.0E-5 | -2.738 | 0.0193 | 0.263 |
84 | RP11-284N8.3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p | 10 | THBS2 | Sponge network | -0.845 | 0.52848 | -2.628 | 0.00636 | 0.262 |
85 | RP11-567M16.1 |
hsa-let-7g-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-345-5p;hsa-miR-616-5p;hsa-miR-671-5p;hsa-miR-769-5p | 10 | SMAD3 | Sponge network | -2.638 | 0.21408 | 0.16 | 0.77852 | 0.26 |
86 | CTD-2554C21.2 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-93-5p | 10 | TGFBR2 | Sponge network | -6.968 | 0.00817 | -2.733 | 2.0E-5 | 0.259 |
87 | RP11-130L8.1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p | 12 | BMPR2 | Sponge network | -4.329 | 1.0E-5 | -1.126 | 0.00109 | 0.259 |
88 | TRHDE-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p | 17 | BMPR2 | Sponge network | -6.205 | 0.01165 | -1.126 | 0.00109 | 0.257 |
89 | RP11-887P2.5 |
hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-576-5p | 11 | THBS1 | Sponge network | -9.865 | 1.0E-5 | -3.751 | 0.0001 | 0.255 |
90 | RP11-389C8.2 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-93-5p | 12 | TGFBR2 | Sponge network | -3.089 | 2.0E-5 | -2.733 | 2.0E-5 | 0.253 |
91 | RP11-597D13.9 |
hsa-let-7d-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-92a-3p | 11 | THBS1 | Sponge network | -2.494 | 0.07597 | -3.751 | 0.0001 | 0.253 |
92 | LINC00672 |
hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-93-5p | 12 | TGFBR2 | Sponge network | -2.547 | 4.0E-5 | -2.733 | 2.0E-5 | 0.252 |
93 | RP11-597D13.9 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p | 12 | THBS2 | Sponge network | -2.494 | 0.07597 | -2.628 | 0.00636 | 0.252 |